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ABSTRACT
Subcellular Distribution of Apoptosis Associated Speck-like Protein
Mediates Inflammasome Assembly: A Novel Mechanism in the Regulation
of Interleukin-1beta Release
Nicole B. Bryan
Inflammation is an essential component of the innate immune defense
against pathogens. The process of inflammation is mediated by the rapid
release of intercellular mediators, which function in the activation and recruitment
of cellular components of both the innate and adaptive immune system.
However, dysregulation of this process, resulting in sustained inflammation is the
underlying cause of a number of common pathological conditions. These include
hereditary autoinflammatory disorders, gout, arthritis, asthma, and cancer.
Furthermore, IL-1beta is a key component of the tumor microenvironment, which
serves to recruit tumor-associated macrophages, promote angiogenesis,
enhance NF-kB activation, and suppress anti-tumor immunity. The studies
presented here explore novel regulatory mechanisms of IL-1beta maturation
through the modulation of the inflammasome adaptor protein ASC. ASC is an
intriguing protein, which participates in both inflammatory and apoptotic pathways
and is frequently silenced by aberrant methylation in a large number of cancers.
It is a small protein, consisting of only two protein-interaction domains, an Nterminal PYD, and a C-terminal CARD. Numerous studies have found that it is
required for inflammasome assembly following activation of a number of diverse
cytoplasmic NLR receptors. Therefore, regulation of this protein has broad
implications for IL-1beta maturation.
In the first study, we examined the endogenous localization of ASC.
Several independent research groups had found that ectopic expression of ASC
results in several distinct localization patterns including nuclear, cytoplasmic, and
the formation of a characteristic perinuclear aggregate termed a ‘speck’.
However, the subcellular distribution of endogenous ASC had never been
evaluated. Therefore, we examined the subcellular localization pattern of ASC in
several monocytic cell lines as well as in primary monocytes and macrophages.
We discovered that in resting monocytes, ASC is localized diffusely throughout
the nucleus. However, upon inflammatory stimulation of the cells, we determined
that ASC was rapidly redistributed to the cytoplasm where it subsequently formed
a perinuclear aggregate, reminiscent of the ‘specks’ observed upon
overexpression of this protein. Furthermore, we determined that other core
inflammasome proteins NLRP3 and caspase-1 co-localized with ASC in these
aggregates, suggesting that they represent inflammasomes. Additionally, we

found that nuclear export of ASC is necessary for proper inflammasome
assembly and processing of IL-1beta.
In Study 2, we identified Mycoplasma sp. as a novel activator of the
inflammasome. Infection with Mycoplasma sp. cause a number of organ-specific
diseases in humans, and they have also been linked to a number of proinflammatory disorders. Therefore, we hypothesized that IL-beta played a role in
the innate immune defense against these pathogens. We discovered that
incubation of monocytes and macrophages with either live or heat-killed
Mycoplasma sp. stimulated the secretion of mature IL-1beta at levels comparable
to those observed with known inflammasome activators. Furthermore, we also
determined that Mycoplasma infection induced the nuclear to cytoplasmic
translocation of ASC, as well as the formation of perinuclear aggregates, just as
we observed with known inflammasome activators in Study 1. Finally, we
showed that Mycoplasma-induced release of IL-1beta was dependent upon ASC,
further indicating the role of the inflammasome in this process. Based upon this
data, we hypothesize that chronic infection with Mycoplasma sp. results in
sustained production of IL-1beta, which leads to a prolonged inflammatory state.
In our third and final study, we identified and characterized three ASC
isoforms with regards to their subcellular localization, and their ability to function
as an inflammasome adaptor protein. ASCb lacks the linker domain, ASCc
possesses an in-frame deletion in the PYD, which does not disrupt the linker
region or the CARD, and ASCd expresses only the first 35 amino acids of the
PYD, which is fused to a novel peptide. Upon ectopic expression, each isoform
exhibited a different localization pattern, and none of them formed the classic
perinuclear ‘speck’, which has become the hallmark of full-length ASCa. Upon
co-expression with either NLRP3(R260W) or caspase-1, co-localization was only
observed by those isoforms, which expressed a fully intact PYD or CARD,
respectively. Functionally, only ASCb was able to mediate IL-1beta processing
when co-expressed with NLRP3(R260W) and pro-caspase-1, although to a lesser
extent, presumably because neither of its protein interaction domains were
disrupted.
In summary, these studies show novel mechanisms by which IL-1beta
release is regulated and induced. The discovery of novel ASC isoforms and the
role its subcellular distribution plays in the regulation of IL-1beta processing
provide us with new insights into how inflammasome assembly is regulated and
fin-tuned. Furthermore, the nuclear to cytoplasmic redistribution of ASC provides
us with a potential new therapeutic target that would prevent the release of IL1beta without impacting the expression of ASC.
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Literature Review

Inflammation is an essential component of the innate immune system, and
is required for the elimination of invading pathogens. The process of
inflammation is primarily regulated by cytokines, which are secreted by immune
cells such as monocytes and macrophages. When functioning properly,
inflammation is a key process in protection against viruses, bacteria, fungi and
protozoa. However, excessive production of inflammatory cytokines can inflict a
large amount of unwarranted damage on an individual. This occurs in immunelinked diseases, such as autoinflammatory disorders, which are characterized by
recurrent, unprovoked bouts of fever and inflammation, with no apparent B cell or
T cell involvement.
Interleukin-1
Interleukin-1 (IL-1) is a key cytokine in the inflammatory process. It is
distinguished from other cytokines by the fact that it can initiate a response in
nearly every cell type, and therefore its effects are not limited to immune cells.
This fact, in combination with the ability of IL-1 signaling to result in the
upregulation of numerous other pro-inflammatory cytokines has led many people
to consider it to be a ‘master cytokine’. The IL-1 gene family consists of three
members: IL-1alpha, IL-1beta, and IL-1 receptor antagonist (IL-1Ra). Of these,
only the IL-1Ra, which elicits no response upon interaction with the IL-1 receptor,
possesses a signal sequence that enables it to be secreted from the cell. IL1

1alpha and IL-1beta function as agonists when bound to the IL-1 receptor, and
display similar biological activity upon release from the cell. However, they differ
in their intracellular functionality, their processing from the pro-form to the active
cytokine, and the circumstances under which they are released. IL-1beta is only
synthesized under conditions of cell stress or pathogenic invasion, remains
inactive while in its full-length form, and exhibits no intracellular activity. IL1alpha, on the other hand, is frequently expressed in cells, is active in both its
cleaved and its pro-form, and is believed to exert functions in the nucleus related
to cell differentiation. In addition, IL-1beta requires activation of caspase-1 in
order to be cleaved into its active 17.5 kD form, whereas IL-1alpha is processed
by membrane associated calcium-dependent calpains. Furthermore, IL-1beta is
rapidly synthesized and released under conditions of pathogenic challenge, while
IL-1alpha is usually only released in the context of severe cell stress or necrosis.
Therefore, elevated serum levels of IL-1alpha are associated with a more
devastating disease state than elevated levels of IL-1beta (Dinarello, 1996).
IL-1beta is a very powerful pro-inflammatory cytokine that can exert both
local and systemic effects. Upon its release, it can function as a chemoattractant
for a number of immune cells including neutrophils, monocytes and
macrophages, as well as B and T lymphocytes. Systemically, it is an extremely
potent pyrogen, inducing fever at ng/kg concentrations in healthy human
subjects. Furthermore, upon binding to the IL-1 receptor (IL-1R1), IL-1β can
induce downstream signaling, which results in the transcriptional upregulation of
2

itself as well as other inflammatory cytokines, including TNF-alpha (Dinarello CA,
1987,Warner, 1987). IL-1beta has become a very important cytokine in the
clinical setting as dysregulation of its secretion has been associated with a
number of inflammatory disorders including arthritis, asthma, inflammatory bowel
disease, ulcerative colitis, atherosclerosis, peridontitis, type 2 Diabetes, lung
fibrosis, multiple sclerosis, Alzheimer’s disease, stroke, septic shock, periodic
fever syndromes such as Familial Mediterranean Fever, and cancer (Barksby
HE, 2007,Braddock M, 2004,Samuels, 2006).
A further indication of its key role in inflammatory processes is the extent
to which IL-1β signaling is regulated. IL-1-beta is synthesized as a 31kD precursor, which must be processed into its active 17.5 kD form by either active
caspase-1 or extracellular proteases. Activation of this cytokine is believed to
occur in a two-step process. First, activation of Toll-like receptors stimulated
activation of the transcription factor NF-kappa B. NF- kappa B regulates a large
number of pro-survival as well as pro-inflammatory genes, and among them is
the gene for pro-IL-1 beta. However, TLR signaling alone is insufficient for
complete activation of IL-1 beta. The second step of the process requires the
activation of caspase-1 in order to convert pro-IL-1 beta into its active, mature
form, which is subsequently secreted from the cell. Thus, there are two distinct
requirements for activation of IL-1 beta, which must both be fulfilled in order for
the active cytokine to be released from the cell, although under certain conditions

3

other inflammatory caspases, such as caspase-5 (human) or caspase-11
(mouse), are required for IL-1beta processing (Netea MG, 2008).
Intriguingly, the mechanism of the release of IL-1alpha and IL-1beta has
still not been fully elucidated. Both IL-1 beta and IL-1 alpha lack a signal
sequence, and neither has been found to localize to the ER, or to the Golgi
apparatus, and inhibition of trafficking in these membrane systems had no impact
on the release of IL-1 beta. Furthermore, Rubartelli et al., demonstrated that
viable cells are required for release of the active form of IL-1 beta, and that only
pro-IL-1 beta is released upon cell lysis, suggesting IL-1 is released by a nonclassical secretion pathway (A Rubartelli, 1990). Recently, a study has emerged
implicating caspase-1 as the key regulator for the secretion of both IL-1 beta and
IL-1 alpha as well as some other proteins known to be secreted by in a nonclassical manner. These researchers discovered that the secretion both IL-1
beta and IL-1 alpha, which is not a substrate for caspase-1, was impaired in
macrophages derived from caspase-1-/- mice. Furthermore, they showed that the
enzymatic activity of caspase-1 is required in order for it to mediate protein
secretion, and that loss of NALP3, and ASC also resulted in a decrease in IL-1
alpha secretion. Finally, this group identified other leaderless secreted proteins,
whose secretion may be regulated by caspase-1 including FGF-2, which
functions in angiogenesis and tissue repair (Keller M, 2008). These data suggest
that caspase-1 may have an additional role in the regulation of inflammation and
wound repair, distinct from its cleavage of pro-IL-1 beta.
4

Once active IL-1 has been released from the cell, there are further
mechanisms to mitigate its signaling potential. First, there are two potential IL-1
receptor proteins, IL-R1, IL-1R2, and a soluble, shedded IL-1R1. Only the IL-R1
possesses a cytoplasmic tail, which can transmit downstream signaling upon
binding to IL-1-beta. When IL-1-beta binds to IL-1R1, it is initially a low affinity
interaction. However, a conformational change occurs in the receptor, which
enables it to subsequently bind to the IL-1 accessory protein (IL-1R AcP), which
results in a higher affinity interaction and is necessary for transmission of
downstream signaling. The IL-1R2 and the soluble IL-1R1, on the other hand,
lack the cytosolic domain and functionally serves as a decoy receptor, though its
initial binding to IL-1β results in a more stable interaction. Cells expressing the IL1 receptors will express ten times more of the non-signaling IL-1R2 than IL-1R1
as an additional safeguard against unwarranted IL-1 signaling.
Circulating monocytes and adherent macrophages serve as major
producers of IL-1 beta. Monocytes are circulating blood cells produced in the
bone marrow by hematopoeisis. They are a member of the myeloid lineage of
blood cells, and play a crucial role in innate immunity. Macrophages are derived
from circulating monocytes and are found in numerous tissues throughout the
body. They arise through the differentiation of monocytes, which occurs when
they extravasate from the vasculature and enter the tissue spaces. They are
distinguished from monocytes by the fact that they are much larger and adherent.
In addition, many tissues, which frequently encounter pathogenic challenges,
5

such as the lungs and GI tract, maintain a resident population of macrophages.
Both monocytes and macrophages possess phagocytic abilities and can serve as
antigen presenting cells for cytotoxic and helper T cells. Furthermore, they are
both capable of secreting numerous inflammatory cytokines, which can function
as chemotactic factors for other innate as well as adaptive immune cells.
However, for many years it has been known that monocytes and
macrophages exhibit differential requirements in order to secrete active IL-1 beta.
Specifically, numerous studies with macrophages demonstrated a requirement
for extracellular ATP in addition to bacterial ligands such as LPS. No such
requirement has been documented for monocytes. Furthermore, monocytes are
capable of secreting larger amounts of IL-1 beta in comparison with
macrophages. Fortunately, recent evidence has emerged that may begin to
explain these differences, which have long been a mystery to researchers. First,
the Rubartelli lab demonstrated that monocytes could secrete ATP in response to
several different bacterial ligands as well as uric acid. The amount of mature IL-1
beta and IL-18 secreted by these cells was closely correlated with the amount of
ATP they released. Therefore, they proposed that the ATP secreted by
monocytes can act in an autocrine manner in order provide the additional
stimulation required for IL-1 beta and IL-18 release. Data, which showed that
blocking the P2X7 receptor, which binds extracellular ATP, prevents release of
the mature cytokines, but not intracellular accumulation of the precursor forms,
provided support for this hypothesis (Piccini A, 2008). Additional studies in the
6

Dinarello laboratory confirmed these results and also provided new insights.
They found that monocytes constitutively express the active p10 subunit of
caspase-1 in addition to the inactive p45 precursor, while macrophages only
express the inactive precursor. Furthermore, they determined that prevention of
adherence of differentiated monocytes resulted in maintenance of their ability to
secreted active IL-1 beta in the absence of ATP (Netea MG, 2009).
The process of inflammation is intimately intertwined with those involved in
the development and progression of cancer. First, many cancers develop at
sites of chronic inflammation or infection. Among them are gastric cancer, which
is strongly linked to chronic infection with the bacterium H. pylori, and colon
cancer, which often develops in the setting of inflammatory bowl disease. In
addition, a large portion of the tumor microenvironment is composed of
inflammatory cells. Numerous studies have demonstrated the importance of the
microenvironment in tumor survival, proliferation and metastasis. Macrophages
are one of the essential inflammatory cell components in the tumor
microenvironment. They are frequently recruited to the tumor site by tumor cell
mediated secretion of the cytokine monocytes chemoattractant protein 1 (MCP1).
Once recruited to the site, tumor associated macrophages (TAMs) are capable of
either inhibiting or promoting tumor growth. TAMs can also aid in the process
tumor invasion through the stimulation of angiogenesis and by secreting matrix
metalloproteinases (MMPs), which degrade the extracellular matrix to enable
tumor cell invasion (Ono, 2008).
7

The role of inflammatory cytokines is increasingly being evaluated in the
context of cancer. Evidence has accumulated, which indicates that an
appropriate balance of inflammatory cytokines must be present in order for tumor
development to occur. In the presence of excessive inflammation, tumor
regression will occur. However, too few cytokines present will restrict tumor
growth. While the necessity of proinflammatory cytokines for tumor progression
appears counterintuitive at first glance, a deeper look reveals that a chronic
inflammatory state effectively provides a fertile environment, which can nurture
tumor growth. Many of the cellular processes stimulated by pathogenic invasion
or wound healing are also advantageous to neoplastic cells. Inflammatory
cytokines induce proliferation, recruit inflammatory cells, and also stimulate an
increase in the production of reactive nitrogen and oxygen species, which can
cause DNA damage. This DNA damage can be further exacerbated by
cytokines, which can overcome p53 regulatory control. Thus, chronic
inflammation results in an environment in which cell proliferation is enhanced,
there is an increase in DNA damage, and normal cell cycle controls are
bypassed, all of which also enhance tumor development (Coussens LM, 2002).
Recently, IL-1beta has emerged as a key inflammatory player in tumor
progression and invasiveness. It is often secreted by TAMs and elevated levels
of IL-1beta in the tumor microenvironment result in an increase in the production
of angiogenic factors including VEGFA, and IL-8. A recent study documented
that in IL-1beta deficient mice, there was decreased rate of chemically-induced
8

tumorigenesis, less leukocytic infiltrate surrounding tumors, and decreased
invasiveness (Krelin, 2007). Furthermore, cancer cells frequently acquire the
ability to secrete IL-1beta, which can act synergistically with the IL-1 produced by
the tumor microenvironment to enhance tumor growth and invasiveness (Kimura
YN, 2007).
One tumor setting in which increasing evidence has emerged for the
critical importance of IL-1beta signaling is gastric cancer. In one recent study,
treatment of several gastric cancer cell lines with IL-1beta was found to induce
methylation of the E-cadherin gene, which is an important event in the
development of gastric carcinogenesis (Qian X, 2008). Downregulation of Ecadherin is an essential step in the process of epithelial to mesenchymal
transition (EMT), which is important for tumor cell invasion and metastasis. Tu et
al recently generated an IL-1beta tissue specific transgenic mouse, which they
utilized to demonstrate that chronic overexpression of IL-1beta in the stomach is
sufficient for the development of metaplasia, and even high grade
dysplasia/carcinoma in the absence of H. pylori infection. Furthermore, they
found that expression of IL-1beta could recruit myeloid derived suppressor cells
to the tumor site. These cells have been found to enhance tumor progression
and invasion in a manner similar to TAMs in addition to their ability to suppress B
and T cell proliferation (Tu S, 2008).

9

The Inflammasome
In recent years, evidence has accumulated in favor of an activation
platform serving as the site of activation of IL-1beta. This platform is composed
of a multi-protein aggregate and is referred to as the inflammasome. The initial
description of the inflammasome included the proteins caspase-1, caspase-5,
ASC, and the cytosolic receptor NLRP protein NALP-1 (Bruey, 2004,Martinon,
2002). Furthermore, ASC was determined to be an essential component of the
inflammasome in order to achieve activation of caspase-1 and caspase-5.
Additionally, NLRP3 (Cryopyrin) was also identified as a participant in
inflammasome formation (Kanneganti, 2006b,Mariathasan, 2006,Martinon,
2006,Sutterwala, 2006). However, an inflammasome containing NLRP3 could
only stimulate caspase-1 activation, not caspase-5 (Agostini, 2004). The
essential role of ASC in formation of these complexes was further solidified by
the generation of ASC-null macrophages and mice. The absence of ASC
severely diminished the ability of the macrophages to secrete IL-1β or to respond
to intracellular pathogens. In the mice, the absence of ASC prevented the
development of endotoxic shock in response to LPS (Mariathasan,
2004,Yamamoto, 2004).
Inflammasome assembly is initiated when the ligand-sensing region (LRR
domain) of a cytosolic NLR receptor recognizes a specific molecular pattern.
These molecules may be derived from conserved regions of invading pathogens,
such as bacterial lipopolysaccharide (LPS) or peptidoglycan. In addition, certain
10

endogenous molecules such as ATP and uric acid can also be recognized as
danger signals. The recognition of a specific ligand is then followed by the
recruitment of the adaptor protein ASC via a homotypic PYD-PYD interaction
between the N-terminal domain of ASC and the N-terminal protein interaction
domain of the receptor. Once recruited, ASC subsequently recruits the inactive
pro-caspase-1 via a homotypic CARD-CARD interaction. Recruitment of multiple
pro-caspase-1 molecules results in their activation via the induced proximity
mechanism.

Schematic 1: The linear structure of key inflammasome proteins. The
cytosolic NLRP receptor consists of an N-terminal protein interaction domain
(PYD), a nucleotide-binding oligomerization domain (NACHT), and a c-terminal
ligand-sensing domain (LRR). The adaptor protein ASC is recruited to the NLRP
receptor via homotypic PYD-PYD interaction. ASC then uses its CARD domain
to recruit pro-caspase-1 via homotypic CARD-CARD interaction. Pro-casapse-1
molecules then undergo autocatalytic processing generating the active form of
the caspase with p20 and p10 subunits (red and white). PYD = PYRIN domain
(blue), NACHT = neuronal apoptosis inhibitory protein (NAIP)/MHC class II
transcription activator (CIITA)/incompatibility locus protein from Podospora
auserina (HET-E)/telomerase-associated protein (TP1) (orange), LRR = leucine
rich repeat (green), CARD = caspase recruitment domain (yellow).
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The NLR family of proteins function as cytosolic pattern recognition
receptors, which recognize specific microbial pathogen associated molecular
patterns (PAMPs) as well as endogenous danger associated molecular patterns
(DAMPs). Structurally, these proteins consist of an N-terminal protein interaction
domain, which is frequently either a PYD or a CARD domain, a central nucleotide
binding NACHT domain, and a C-terminal region of leucine rich repeats (LRR).
To date, more than twenty cytosolic NLR receptor proteins have been identified.
Of these, fourteen possess a PYD domain at the N-terminus, which functions as
their protein interaction domain. The receptors studied thus far, even those with
a CARD, require the adaptor protein ASC in order to recruit and activate
caspase-1. Upon recognition of a specific PAMP or DAMP by the LRR domain,
the receptor then undergoes an ATP-dependent oligomerization, which results in
the unmasking of the protein-interaction domain thereby enabling it to recruit the
adaptor protein ASC, or in some instances, caspase-1 directly (Faustin B, 2007).
Interestingly, in addition to serving as the recognition domain the LRR domain of
the NLR receptors is also instrumental in preventing unwarranted inflammasome
activation, presumably by masking the protein-interaction domain. Deletion of
the LRR domain of NLR proteins results in constitutive inflammasome activation
and IL-1 beta secretion in the absence of any activation by pathogens or
endogenous danger signals (Faustin B, 2007).
NLRP3 /cryopyrin is the most studied and best characterized member of
the NLR family. Missense mutations in the NACHT domain of this receptor result
12

in the hereditary autoinflammatory disorders collectively known as the
cryopyrinopathies, which include a spectrum of diseases, ranging in severity. The
specific NLRP3 diseases are familial cold autoinflammatory syndrome (FCAS),
which is the mildest form, Muckle-Wells syndrome, and chronic infantile
neurologic cutaneous and articular (CINCA) syndrome, which is the most severe
(Kastner, 2005,Tschopp, 2003). The mutations associated with these diseases
result in constitutive activation of NLRP3, which subsequently recruits ASC on a
continuous basis. This results in sustained activation of the inflammasome and
IL-1β secretion (Agostini, 2004,Dowds, 2004,Masumoto, 2003,Yu, 2006). The
mutations commonly associated with these diseases are an arginine to tryptophan
substitution at residue 260 (R260W), an aspartic acid to asparagine substitution at
residue 303 (D303N), and a tyrosine to cysteine substitution at residue 570
(Y570C). The R260W mutation has been identified in both FCAS and MuckleWells syndrome. The D303N mutation is observed in Muckle-Wells syndrome
and CINCA, while the Y570C mutation is seen in the most severe cases of
CINCA.
Interestingly, the NLRP3 mutations, which are associated with increased
inflammasome activation, have also been found to induce cell death as well. The
Miyachi lab demonstrated that transfection of the common NLRP3 mutants, but
not the wild type, into the monocytic THP-1 cell line resulted in cell death. The
cell death was apparent shortly after gene expression, as measured by Annexin
V staining. Further analysis revealed that the cell morphology was indicative of a
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necrotic type death, and was dependent upon the release of the lysosomal
protein cathepsin B and accompanied by mitochondrial damage. Furthermore,
cell death was also observed in THP-1 cells transfected with wild-type NLRP3
following treatment with the NLRP3 specific activator R837 (Fujisawa A, 2007).
That the cell death induced by NLRP3 mutants exhibited a closer resemblance to
necrosis rather than apoptosis is fitting with their role in autoinflammatory
disorders. Necrotic cell death is frequently associated with a local inflammatory
response and recruitment of phagocytic cells, whereas apoptosis is not.
Additionally, upon pathogenic invasion, cells will frequently favor a necrotic death
as a mechanism to elicit a more robust immune response.
To date, several ligands have been identified, which activate the NLRP3
inflammasome. Among them are several pathogen-derived molecular patterns
as well as endogenous danger signals. They include bacterial RNA (Kanneganti,
2006b), double-stranded viral RNA (Kanneganti, 2006a), muramyl dipeptide
(Marina-García N, 2008,Martinon, 2004), gout-associated uric acid crystals
(Martinon, 2006), extracellular ATP (Mariathasan, 2006), K+ efflux (Pétrilli V,
2007), silica (Cassel, 9035), asbestos (Dostert, 2008), ROS (Cruz CM, 2007),
influenza A (Thomas PG, 2009), and amyloid beta (Halle A, 2008). The number
of ligands capable of triggering the NLRP3 inflammasome is particularly
intriguing given that many of the known NLR receptors have yet to be associated
with a specific ligand.
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The precise mechanism by which ligands activate NLR receptors has not
been fully elucidated as a physical interaction between an NLR protein and a
pathogenic molecular pattern has never been demonstrated. Therefore, it is
possible given the large number of diverse ligands identified for NLRP3 and
NLRC4, that the receptor is indirectly activated by a common alteration in
endogenous molecules rather than through a direct interaction with the agonists.
However, one requirement for NLRP3 and NLRC4 receptor activation that is well
established is the transport of the activating ligand to the cytoplasm (Juhas M,
2008,Kanneganti TD, 2007 ). Some pathogens encode genes for pore-forming
toxins, such as Streptococcus, which enable the transport of exogenous
substances into the cytoplasm (Marriott HM, 2008). Other pathogens, such as
Salmonella and Legionella possess Type III or Type IV secretion systems, which
enable them to deliver bacterial components to the cyotosol once they have been
phagocytosed (Galán JE, 2006,Juhas M, 2008). Mutational studies with these
bacteria have demonstrated that these systems are essential for caspase-1 and
IL-1beta activation. For those pathogens that lack these capabilities, a
cytoplasmic delivery mechanism has been identified, which involves activation by
ATP, and is closely associated with activation of NLRP3.
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Schematic 2. Mechanisms of cytoplasmic delivery of NLRP3 activating
ligands. Inflammasome activation requires the cytoplasmic delivery of the
activating ligands. This can be achieved by pathogen-encoded pore-forming
toxins or secretion systems. Alternatively, cytoplasmic delivery can be mediated
by the opening of membrane channels. The P2X7 receptor is activated upon
binding of extracellular ATP, which functions as a DAMP, and subsequently
enables the rapid loss of intracellular K+ and the opening of the large membrane
channel, pannexin-1. The opening of the pannexin-1 channel allows the delivery
of pathogenic ligands. In addition, the phagocytosis of undigestable materials,
such as asbestos, causes phagosomal destabilization resulting in the
cytoplasmic delivery of cathepsin B, which functions as an NLRP3 ligand.
ATP, which serves as a particularly potent endogenous danger signal, is
an interesting activator of the inflammasome. Extracellular ATP binds to the
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purigenic P2X7 receptor and gene ablation studies in mice have demonstrated
that it is required for the release of IL-1beta in response to ATP (Solle M, 2001).
When activated, this receptor functions as a cation channel, which results in the
immediate efflux of intracellular potassium. In addition, stimulation of this
receptor also causes the gradual opening of a larger pore, which is permeable to
molecules up to 900 Da in size. Recent studies have identified that the opening
of this larger pore is mediated by the hemichannel protein pannexin-1 (Locovei S,
2007). Pelegrin et al demonstrated that the P2X7 receptor and pannexin-1 are
frequently co-expressed in cells and are found co-localized in the cell membrane.
Furthermore, they showed that knock-down of pannexin-1 prevented dye uptake
by cells in response to ATP activation as well as activation and release of IL1beta, but had no impact on potassium efflux. Finally, they also showed that
overexpression of pannexin-1 in P2X7 receptor-null cells caused an increase in
the cellular uptake of ethidium, which was not observed in cells that expressed
the P2X7 receptor. This evidence suggests that the P2X7 receptor functions as
an inhibitor of pannexin-1-mediated pore formation in resting cells, and that this
inhibition is relieved upon binding of ATP to the P2X7 receptor (Pelegrin P, 2006).
Recent evidence suggests that pannexin-mediated pore formation may
serve as a delivery mechanism, which results in the activation of NLRP3. The
Nunez laboratory demonstrated that NLRP3 and ASC are required for activation
of caspase-1 in macrophages stimulated with a panel of heat-killed bacteria and
ATP. Furthermore, they found that incubation of macrophages with heat-killed
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bacteria in the presence of the pore-forming toxin streptolysin O (SLO) could
bypass the requirement for ATP and generate active caspase-1 in a NLRP3dependent manner. Finally, this group was able to restore caspase-1 activation
by Salmonella, Listeria, and Franciscella, which were deficient in their respective
pore-forming toxins or secretion systems, by incubating them with macrophages
in the presence of ATP. Furthermore, this activation was dependent upon both
pannexin-1 and NLRP3 (Kanneganti TD, 2007 ). Subsequent studies have
provided further support for the intracellular delivery of bacterial products
mediated by pannexin-1. Muramyl dipeptide (MDP) is a component of
peptidoglycan. Recent evidence has emerged, which show that this molecule is
taken up by bone marrow derived macrophages (BMDM), and that it localizes in
acidified vesicular structures. Stimulation with ATP causes a rapid redistribution
of MDP from these compartments to the cytoplasm. Inhibition of pannexin-1
abrogated this localization change. Furthermore, caspase-1 activation was
absent in macrophages derived from NLRP3-null mice in response to MDP and
ATP stimulation. These data provide additional evidence that the pore formed by
pannexin-1 delivers pathogenic molecular patterns to the cytoplasm resulting in
the activation of the NLRP3 inflammasome (Marina-García N, 2008).
New evidence has emerged, which links aberrant secretion of IL-1beta to
other clinically relevant disease processes. Recently, activation of the NLRP3
inflammasome has been implicated in the pathogenesis of the occupational
pneumoconioses silicosis and asbestosis. Studies have demonstrated that
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alveolar macrophages secrete IL-1 beta in response to treatment with silica
crystals in a NLRP3, ASC, and caspase-1 dependent manner. Furthermore,
gene ablation studies for each of these proteins resulted in a decrease in lung
inflammation and fibrosis, indicating that inflammasome activation is necessary
for the development of this disease (Cassel SL, 2008). Additional studies have
revealed that the mechanism behind the involvement of the inflammasome in the
development of silicosis, and other crystals is destabilization of phagasomes.
The Latz laboratory has shown that phagocytosis of silica crystals results in a
rupture of lysosomes, which then leak their contents into the cytoplasm of the
cell. Their evidence suggests that NLRP3 recognizes the enzymes, such as
cathepsin B, normally contained within these membrane-bound structures as a
danger signal and initiates downstream activation of caspase-1 (Hornung V,
2008).
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Schematic 3: Activation of the NLRP3 inflammasome. Recognition of
several identified ligands by the LRR domain of NLRP3 triggers assembly of the
inflammasome. NLRP3 undergoes an ATP-dependent conformational change,
which enables it to utilize its PYD to recruit the adaptor protein ASC. ASC
subsequently recruits pro-caspase-1 via CARD-CARD interaction. Once multiple
pro-caspase-1 molecules are brought into close proximity, they are then able to
process each other and release the catalytically active p10 and p20 subunits
from the pro-domain. Active caspase-1 molecules can then cleave 31kD pro-IL-1
beta into its active 17kD form, which is secreted by the cell.
The most recently identified inflammasome ligand is cytoplasmic DNA.
The ability of double-stranded DNA to trigger inflammasome assembly and
subsequent IL-1beta maturation was first discovered by the Tschopp laboratory
in 2008. This group determined that infection with adenovirus, which contains a
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double-stranded DNA genome, elicited secretion of IL-1beta in a NLRP3 and
ASC-dependent manner. Intriguingly, they also observed inflammasome
activation in response to mammalian DNA, when it was introduced into the
cytoplasm. Although the response to mammalian DNA was also ASCdependent, it occurred independently of NLRP3, suggesting the existence of an
alternative sensor molecule (Muruve DA, 2008). At the beginning of 2009, this
receptor was identified by three independent groups, who determined it to be
AIM2 (absent in melanoma 2). AIM2 possesses both a PYD and a HIN200
domain, which is a known nucleotide-binding domain. The presence of these two
domains in its structure renders AIM2 capable of interacting directly with both the
inflammasome adaptor, ASC and DNA, respectively. AIM2 is unique among
previously described receptors in that there is evidence for its direct interactin
with its ligand. AIM2 was found to activate both caspase-1 as well as NF-kB in
an ASC-dependent manner. Additionally, knock-down of this protein abrogated
caspase-1 activation and subsequent IL-1beta secretion in response to
mammalian DNA. These data indicate a role for AIM2-mediated inflammasome
activity in the innate defense against viral pathogens as well as autoimmune
disorders (Burkstummer, 2009, Hornung, 2009, Fernandes-Alnemeri, 2009).
The key inflammasome adaptor protein ASC (Apoptosis associated
Speck-like Protein containing a Caspase recruitment domain) plays a key role in
both apoptosis and inflammation. It was initially discovered by two independent
research groups. The Sagara lab identified it in HL-60 cells subsequent to
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treatment with the DNA-damaging agent (Masumoto, 1999). In this study, it was
noted that ASC formed characteristic perinuclear aggregates in response to the
chemotherapeutic agent and that its structure included a caspase recruitment
domain (CARD) on the c-terminal end. The second research group identified
ASC as a target of methylation-induced silencing in breast cancer and thus was
also named Target of Methylation-induced Silencing-1 (TMS1) (Conway, 2000).
Structurally, ASC is a member of the Death Domain Fold Superfamily
consisting of two death domain fold domains. A PYD, the newest addition to the
death domain fold family, is located at the N-terminus of ASC, and its structure
most closely resembles that of the death effector domain (DED) of human FADD
(Liepinsh, 2003). A CARD is located at the C-terminus, and a short linker
domain joins it to the PYD. While ASC has not been isolated and analyzed by xray crystallography, its PYD has been evaluated using nuclear magnetic
resonance (NMR) spectroscopy. Like other members of the death domain
family, the PYD of ASC consists of six alpha helical folds joined together by loop
regions. Further analysis of revealed that the ASC PYD is very bipolar in that
most positively charged amino acid residues reside in helices two and three,
while the negatively charged ones reside in helices one and four. Based upon
this information, it is predicted that the PYD of ASC is likely to interact in a
homotypic interaction with other PYD-containing proteins via a type I interaction
where helices two and three of one PYD interact strongly with helices two and
three of a second PYD (Liepinsh, 2003).
22

Shortly after its initial discovery, ASC expression was assessed in a
number of normal human tissues by immunohistochemistry, and was found to be
present in several tissues including the kidneys, liver, colon, spinal cord,
placenta, and most significantly in monocytic cells (Masumoto, 2001b).
Conversely, ASC was not observed in cardiac muscle, ciliated epithelium of the
trachea, or in lymphocytes. The group also demonstrated that the localization of
GFP-tagged ASC as well as each of its component domains upon
overexpression. Their studies revealed that both the PYRIN domain and the
CARD domain are required in order for the characteristic aggregates (specks) to
form. Expression of the individual domains of ASC, on the other hand resulted in
formation of long filamentous structures (Masumoto, 2001a). These structures
are reminiscent of the “death filaments” previously characterized as occurring
upon overexpression of individual members of the death domain fold family
(Siegel, 1998). Subsequent studies of the PYD of ASC revealed that amino
acids 1-90 are sufficient in order for these filaments to form, and that they do not
associate with the cytoskeleton, but rather are formed by self-oligomerization. In
addition, positive charge at amino acid residues K21, K26, and R41, as well as a
negative charge at residues D48 and D51 are crucial for filament formation
(Moriya, 2005). Furthermore, the Sagara lab also demonstrated that the PYD
and CARD are capable of binding to each other when co-expressed individually.
These findings have since been independently confirmed by other groups
(Stehlik, 2003b).
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Schematic 4: Localization patterns of overexpressed full-length ASC and
individual domains. Cells immunofluorescently stained for ASC (green), DNA
(blue) and actin (red). Expression of full-length ASC (A) results in the formation
of characteristic perinuclear aggregates termed ‘specks’. However, both the
CARD (B) and the PYD (C) are required in order for these structures to form, as
expression of the individual domains results in the formation of previously
characterized ‘death filaments’.
The initial studies leading to the discovery of ASC provided evidence that
it likely functioned in apoptotic pathways. The loss of ASC expression in breast
cancer cells by methylation-induced gene silencing further implicated it as a
clinically relevant tumor suppressor. Tumor suppressors are proteins, which
present roadblocks in the pathway of cancer development. They often include
proteins, which regulate cell cycle progression, particularly in the context of DNA
damage, and those that are pro-apoptotic. In the course of tumor development,
the genes, which encode these proteins are frequently silenced or mutated,
which clears the way for unregulated proliferation combined with a decrease in
cell death. Importantly, both alleles of a given tumor suppressor gene must be
silenced in order for their loss of function to be complete. This is necessary
because most loss of function mutations are recessive, and therefore one
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functioning allele would be able to generate sufficient protein to compensate for
the loss of the second one. This requirement has become known as the two-hit
hypothesis and was first proposed by Knudson in 1971 in the study of
retinoblastoma (Knudson, 1971). Since the initial study in breast cancer,
numerous studies have determined that loss of ASC expression is not limited to
this type of cancer. Indeed, methylation-induced silencing of ASC has been a
documented occurrence in multiple tumor types including ovarian (Akahira J,
2004,Terasawa, 2004), lung (Virmani, 2003), prostate (Partha M Das, 2006),
glioblastoma (Stone, 2004), hepatocellular (Zhang C, 2007), colorectal
(Yokoyama, 2003), and melanoma (Guan, 2003). Furthermore, methylation of
ASC is associated with an increase in disease aggressiveness in both non-smallcell lung cancer (Zhang Z, 2006) and prostate cancer (Collard RL, 2006). These
studies provide strong support for a functional role of ASC in tumor suppression.
While it has become well established that ASC functions as a proapoptotic protein, the precise mechanism still remains elusive. To date, several
groups have demonstrated a role for ASC in multiple apoptotic pathways. Initial
studies performed by the Vertino laboratory determined that ASC induced
apoptosis in HEK 293 cells in a caspase-9 dependent manner. Using dominantnegative constructs, they showed that inhibition of caspase-9 prevented ASCmediated apoptosis. Additionally, they showed that the CARD domain of ASC
was required (McConnell, 2000). However, studies performed in colon cancer
cells revealed that ASC expression is induced through activation and binding of
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p53, and subsequently initiates apoptosis by mediating the translocation of the
pro-apoptotic protein Bax from the cytoplasm to the mitochondria (Ohtsuka,
2004). Alternatively, studies in breast cancer suggest ASC may mediate
apoptosis through cleavage and activation of caspase-8. While it does not
appear that ASC is necessary for caspase-8 activation following the binding of
death receptor ligands to their respective receptors, ectopic expression of ASC is
sufficient to induce cleavage of caspase-8 resulting in apoptosis in the absence
of any activation of the extrinsic pathway (Parsons MJ, 2006). Furthermore, it
has also been demonstrated that ASC interacts directly with caspase-8 via its
PYD, and that ASC is unable to induce apoptosis in caspase-8 deficient MEFs
(Masumoto, 2003).
Most recently, ASC has been implicated in the process of anoikis. Anoikis
is the term applied to a specific type of programmed cell death that occurs when
the interaction between a cell and its extracellular matrix is disrupted. This
results in a loss of integrin-mediated survival signaling and induction of apoptosis
(Frisch, 1994). In order for cancer cells to metastasize, they must invade into the
basement membrane and surrounding tissues. This process requires them to
survive in an anchorage-independent state, and therefore they must acquire
mechanisms to prevent undergoing anoikis. Intriguingly, Parsons et al. has
demonstrated that ASC is up-regulated in the non-transformed breast epithelial
cell line MCF10A. Furthermore, siRNA-mediated knock-down of ASC resulted in
a delay in detachment-induced cell death and inhibited the accumulation of the
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pro-apoptotic protein Bim (Parsons MJ, 2009). These results provide new insight
into the advantages conferred upon tumor cells with the loss of this protein.
Although the original discovery of ASC occurred in the context of
apoptosis studies, it was soon discovered that it also played a key role in
inflammatory pathways. The first indication that ASC functioned in inflammatory
pathways was the up-regulation of both the protein and mRNA in response to
inflammatory stimuli including LPS, TNF-alpha, and IL-1 beta (Shiohara,
2002,Stehlik, 2003b). Subsequent studies suggested a role for ASC in the
modulation of the activity of the transcription factor NF-kB.
NF-kB is a central transcription factor in inflammatory processes as its
activation results in transcription of a large number of pro-inflammatory genes
including IL-1 beta as well as a number of pro-survival genes. Activation of NFkB is a highly regulated process. Under resting conditions, the active subunits of
NF-kB are sequestered in the cytoplasm by a protein called inhibitor of NF-kB
(IkB). Activation and nuclear translocation of NF-kB occurs when the upstream
regulatory IkB kinase (IKK), which consists of two related kinases (IKK alpha,
and IKK beta) as well as a scaffolding unit (IKK gamma), phosphorylates IkB.
This phosphorylation event results in the polyubiquitination and subsequent
proteosomal degradation of IkB. Upon the release, of IkB, the active p50 and
p65 subunits of NF-kB are able to enter the nucleus and initiate transcription
(Karin, 2000,Perkins, 2004).
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Although several independent research groups have implicated ASC in
the modulation of NF-kB activity, its precise role in this process has not been fully
elucidated. Stehlik et al. demonstrated that overexpression of ASC with the
PYD-containing proteins NALP3 and Pyrin in HEK 293 cells resulted in the
activation of NF-kB. In contrast, the same study demonstrated that
overexpression of ASC as well as other PYD-containing proteins caused an
inhibition in the activation of NF-kB in response to the inflammatory stimulus
TNF-alpha. This inhibition was overcome upon the co-expression of ASC once
again with NLRP3 and Pyrin. Furthermore, an increase in the degradation of
IkB-alpha was observed upon siRNA-mediated suppression of ASC.
Furthermore, this group also showed that ASC inhibited NF-kB activation through
an interaction with the IKK complex mediated by its PYD. These results indicate
that ASC exerts a PYD-dependent inhibitory effect on NF-kB activation, which
can be overcome upon its interaction with either NLRP3 or Pyrin (Stehlik, 2002).
Whether NLRP3 or Pyrin impact NF-kB activation by disrupting the interaction
between ASC and the IKK complex, or whether they utilize ASC to stimulated
IKK activity has yet to be determined.
Other studies have also demonstrated a role for ASC in the activation of
NF-kB upon its co-expression with another NLR family member known as NLRC4
(Ipaf/CARD12/CLAN). NLRC4 is structurally similar to NLRP3 with the exception
that it possesses a CARD domain as its protein-interaction domain rather than a
PYD, and senses cytosolic flagellin (Miao EA, 2006). Masumoto et al
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demonstrated that the interaction between ASC and NLRC4 resulted in an
increase in NF-kB activation that was enhanced upon deletion of the LRR region
of NLRC4. Furthermore, they also confirmed that the increase in NF-kB activity
was mediated by the PYD of ASC (Masumoto, 2003). Another group expanded
on these results and demonstrated that caspase-8 was necessary for NLRC4 and
ASC-mediated NF-kB activation, and that this activation could be inhibited by the
by FLIP, a cellular inhibitor of caspase-8 activation (Hasegawa, 2005). Evaluation
of the role of ASC in cytokine production in response to Porphyromonas gingivalis
also provided support for the hypothesis that ASC actively contributes to NF-kB
activation. The generation of THP-1 monocytic cells with a stable knock-down of
ASC demonstrated that NF-kB activation is delayed and there is a decrease in
p65/p50 DNA binding in the absence of ASC. Furthermore, loss of ASC resulted
in a decrease in IL-6, IL-8, and IL-10 in response to P. gingivalis as well as
several different TLR agonists (Taxman, 2006).
Further evaluation of the role of ASC in inflammatory processes
determined that it directly interacts with pro-caspase-1, which is responsible for
converting pro-IL-1-beta into its active form. This activation occurs via proteolytic
cleavage at the key aspartic acid residue. The interaction between ASC and
caspase-1 is mediated by a homotypic interaction between the CARD domain of
ASC and the CARD domain of caspase-1. In addition, this interaction results in
the processing of caspase-1 into its active form, as well as downstream
processing and release of IL-1 beta and forced oligomerization of the ASC CARD
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domain is sufficient to cause caspase-1 activation (Srinivasula, 2002,Stehlik,
2003b). Furthermore, it was demonstrated that ASC co-localizes with procaspase-1 and recruits it into the characteristic perinuclear aggregates upon
overexpression (Stehlik, 2003b).
The importance of ASC in caspase-1 activation was solidified with the
generation of the knock-out mouse. Morphologically, there are no deficits
observed in these mice in spite of the demonstrated role of ASC in apoptosis.
However, in response to LPS, they are completely impaired in their ability to
generate active caspase-1 and secrete the pro-inflammatory cytokines processed
by caspase-1, IL-1 beta and IL-18. Furthermore, loss of ASC had no impact on
the increased production of pro-IL-1 beta. Therefore, the role of ASC in IL-1 beta
production is limited to processing the precursor into its active form, rather than on
its transcriptional upregulation. Intriguingly, there was no deficit in these mice in
the production of other inflammatory cytokines such as TNF-alpha and IL-6.
Production of these two cytokines is regulated by the transcription factor NF-kB.
Therefore, in mice, loss of ASC does not impair NF-kB activation (Yamamoto,
2004).
Caspase-1 is the first identified a member of a family of cysteine
proteases, which have well-established roles in inflammation as well as apoptosis.
It was initially discovered as the key enzyme required for the generation of 17.5
kD mature IL-1beta from the inactive precursor and thus was termed IL-1
converting enzyme (ICE) (Thornberry, 1992). In addition, activation of caspase-1
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occurs in both monocytic and endothelial cells in response to the same
pathogenic stimuli that initiate IL-1beta secretion such as LPS (Schumann, 1998).
Caspase-1 cleaves pro-IL-1beta at aspartic acid-alanine residues at positions
116-117 and cleaves IL-18 at aspartic acid-tyrosine residues at positions 35-36.
Interestingly, caspase-1 is not responsible for the generation of mature IL-1alpha,
in spite of the similarities observed regarding the bioactivity of these two members
of the IL-1 family (Howard AD, 1991). Consistently, gene ablation studies with
caspase-1 have confirmed its necessity for the maturation of IL-1 beta, as mice
deficient in this protein are severely impaired in their ability to secrete the
processed cytokine upon pathogenic challenge (Li, 1995).
While caspase-1-mediated conversion of pro-IL-1beta to the mature form
occurs in the cytoplasm (Brough D, 2007), other subcellular localization patterns
for caspase-1 have been observed. First, caspase-1 has been found to
redistribute from the cytoplasm to the nucleus in response to treatment with TNFalpha. Furthermore, this nuclear localization is mediated by the pro-domain of
caspase-1 as demonstrated by the fact that both the full-length protein and the
individual pro-domain exhibit a nuclear and cytosolic localization pattern, while the
p10 and p20 domains are restricted to the cytoplasm (Mao, 1998). Interestingly,
elevated expression of caspase-1 and its nuclear localization are associated with
a favorable outcome in neuroblastoma patients, as a strong correlation exists
between caspase-1 expression and patient survival (Nakagawara A, 1997).
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Recently, a novel mechanism for regulating caspase-1 activation has
emerged. Levin et al have demonstrated that thermal stress can inhibit caspase-1
activation by both the NLRP1 and NLRP3 inflammasomes. In addition, they
determined that heat shock caused the sequestration of caspase-1 into an
insoluble fraction, which may indicate its incorporation into a large inhibitory
protein complex (Levin TC, 2008). Considering both caspase-1 substrates IL1beta and IL-18 are potent endogenous pyrogens, the increase in body
temperature caused by these cytokines may function as an important negative
feedback mechanism to prevent their excessive release.
Like ASC, caspase-1 has also been implicated in NF-kB activation. Unlike
maturation of IL-1beta, this activation is independent of caspse-1 enzymatic
activity as the enzymatically inactive mutant retains the ability to activate NF-kB.
In addition, the CARD domain, which is only present in pro-caspase-1 is both
necessary and sufficient for this function. One mechanism by which caspase-1
achieves NF-kB is through binding to RIP2 via CARD-CARD interaction (Lamkanfi
M, 2004).
Interestingly, one mechanism by which ASC may modulate NF-kB
activation is by exerting influence on the interaction between caspase-1 and RIP2.
While at low levels, ASC can stimulate NF-kB activation; at higher expression
levels ASC disrupts the interaction between caspase-1 and RIP2, which results in
a decrease in NF-kB activation, but an elevation in IL-1beta secretion. Therefore,
ASC may compete with RIP2 for caspase-1 binding in order to engage it in
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inflammasome-mediated IL-1beta activation and down-regulate NF-kB activation.
In monocytes, the pathway, which is favored by caspase-1, may be time
dependent. At early time-points, activation of NF-kB would be necessary in order
to generate the IL-1beta precursor. However, at later times caspase-1 would be
redirected from NF-kB activation to the task of IL-1beta processing (Sarkar, 2006).
Like ASC, the functional role of caspase-1 does not appear to be strictly
limited to inflammatory processes. Recent evidence has accumulated in favor of
caspase-1 serving as the primary mediator of an inflammatory form of apoptosis,
which has been termed pyroptosis. While other members of the caspase family of
proteases have long been established to be key players in both the intrinsic and
extrinsic apoptosis pathways, gene ablation studies with caspase-1 have found no
functional deficit in response to normal apoptotic stimuli. The process of
pyroptosis is primarily distinguished from apoptosis by its inflammatory nature.
The process of apoptosis causes characteristic morphological changes that
include DNA condensation and the dissociation of the cell into membranecontained fragments. These fragments can then be phagocytosed and their
contents recycled. One key hallmark of this process is that no inflammation or
tissue disruption occurs because all of the intracellular contents remain contained
within the membrane fragments. Pyroptosis, on the other hand, is characterized
by loss of cell membrane integrity and the release of intracellular contents, which
initiate a pro-inflammatory response. Furthermore, it is dependent upon caspase1, rather than the classical apoptotic caspases. This type of cell death was
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initially observed and characterized in response to infection with intracellular
bacteria Salmonella and Shigella. However, subsequent studies have found that
it can also occur in response to extracellular bacterial ligands such as LPS
(Bergsbaken T, 2009,Fink SL, 2005,Fink SL, 2006).
While the role of caspase-1 in mediating pyroptotic cell death is widely
accepted, there is some controversy regarding the necessity of ASC for this
process. Recently, the Alnemri lab proposed the formation of the pyroptosome, a
supramolecular assembly, similar to the inflammasome, in which ASC oligomers
serve as a platform for caspase-1 activation. By generating THP-1 cells, which
stably express GFP-ASC at endogenous levels, theses researchers were able to
observe the formation of small, perinuclear ‘specks’ following treatment with
bacterial ligands such as LPS. Furthermore, the formation of these structures
preceded cell death, which possessed the morphological characteristics of
pyroptosis by only a short time as determined by live-cell imaging (T FernandesAlnemri, 2007). However, studies performed by another group with the
intracellular bacterium Shigella flexneri, found that while caspase-1 and NLRC4
were essential to Shigella-induced pyroptosis, ASC was not required. Upon
infection of macrophages derived from caspase-1 or NLRC4 deficient mice, this
group found that the release of the pyroptosis marker LDH was delayed.
However, no such change in kinetics was observed in macrophages derived from
ASC-null mice. These results suggest that ASC is dispensable for pyroptotic cell
death. One explanation for this result offered by the researchers is that ASC may
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promote survival of infected macrophages in the absence of caspase-1 or NLRC4.
This possibility would coincide with previous reports establishing ASC as an
activator of NF-kB (Suzuki T, 2007).

Regulation of the Inflammasome
Regulation of inflammasome formation and activation is an ongoing area
of research. Currently, the primary regulatory mechanism that has been identified
is the existence of small, single-domain proteins, which function in a dominantnegative capacity and thereby disrupt key protein interactions within the
inflammasome complex. These regulatory proteins can be divided into two
distinct categories, based upon the area they target within the activation platform.
Those consisting of an individual PYRIN domain function by disrupting the
interaction between the NLR receptor and the key adaptor protein ASC, and are
frequently referred to as PYRIN-only-proteins or POPs. The regulatory proteins in
the second category are composed of an individual CARD domain, which is
utilized to interfere with the recruitment of caspase-1 to the central adaptor ASC.
These proteins are broadly termed CARD-only-proteins or COPs (Stehlik C,
2007).
The first PYRIN-only protein to be characterized was termed POP1. The
gene encoding this protein is found on chromosome 16p12.1, which is the same
area where the gene for ASC is found. Furthermore, the amino acid sequence of
POP1 was determined to be 64% identical with the PYD of ASC and
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immunostaining revealed that while POP1 localized diffusely to the nucleus and
cytoplasm of the cell, it was recruited into the characteristic ‘speck’ structures
when co-expressed with ASC. Functionally, POP1 exhibits the ability to
modulate activation of ASC-mediated inflammatory pathways including NF-kB
activation and IL-1 beta secretion (Stehlik, 2003a). In addition, further studies
have revealed the binding region of the ASC, where it interacts with POP1.
POP1 interacts with a negatively charged region of ASC located on the first and
fourth helices, which includes aspartic acid residues at residues 6, 13, and 48,
and a glutamic acid residue at residue 13 (Srimathi T, 2008).
Recently, our laboratory in addition to others identified and described an
additional cellular pyrin only protein, cPOP2. We demonstrated that this protein
interfered with caspase-1-mediated IL-1 beta processing. This inhibition is most
likely achieved via direct interaction between cPOP2 and ASC as well as cPOP2
and the NLRP receptor PAN1. Other potential binding partners for cPOP2
include PAN2, NLRP12, and NLRP1 as demonstrated by yeast-2 hybrid assay
(Dorfleutner, 2007a). In addition, cPOP2 has also been found to hinder NFkappa B activation in response to both TNF-alpha stimulation and
overexpression of p65. Furthermore, expression of cPOP2 decreased nuclear
accumulation of p65 (Bedoya F, 2007). Analysis of the subcellular localization of
cPOP2 revealed that its localization was very similar to that of POP1 in that it
localized diffusely throughout the cell when expressed alone and was recruited
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into the perinuclear aggregate ‘speck’ structures upon co-expression with ASC
(Bedoya F, 2007,Dorfleutner, 2007a).
In addition to the cellular POPs, genomic studies of several viruses have
yielded the discovery of viral counterparts to these regulators of inflammasome
activation. These proteins likely evolved as a mechanism to aid the viruses in
their evasion of the host immune system by preventing the maturation and
secretion of IL-1beta. The initial discovery of a viral protein capable of
modulating inflammasome function was made in the rabbit Myoxma virus. This
viral POP is located on the M13L gene of the virus. The product of this gene was
determined to block casapse-1 processing and subsequent IL-1 beta and IL-18
processing and secretion. This inhibition is most likely achieved via direct
interaction with the adaptor protein ASC as it has been demonstrated to both colocalize and directly bind to ASC via PYD-PYD interaction (Dorfleutner,
2007b,Johnston JB, 2005). Furthermore, deletion of this protein from the virus
resulted in decreased viral dissemination and prevented viral replication in
lymphocytes and peripheral blood mononuclear cells. Loss of this protein also
resulted in more rapid disease resolution underlining its importance in
maintaining the virulence of this virus (Johnston JB, 2005)
In addition to the Myxoma virus, another Poxvirus, the Shope Fibroma
virus (SFV), also encodes a POP. Upon transfection, this protein localizes
diffusely throughout the nucleus and cytoplasm at forty-eight hours followed by
the formation of punctate structures at seventy-two hours. In addition, upon co37

expression with the inflammasome adaptor protein ASC, the SFV POP is
recruited to the characteristic perinuclear ‘speck’. These localization patterns are
reminiscent of those of the Myxoma viral POP as well as cPOP1. Functionally,
the SFV POP is also capable of inhibiting IL-1 beta secretion, and both the SFV
and Myxoma POPs activate NF-kB. While this activation may initially appear
counterintuitive due to the numerous anti-inflammatory genes under the
regulation of NF-kappa B, this transcription factor is very commonly activated by
a number of viruses, possibly as a mechanism to prevent virally mediated
apoptosis in host cells (Dorfleutner, 2006).
The second group of inflammasome regulatory proteins, the CARD-only
proteins (COPs) function in a manner similar to that of the Pyrin-only proteins.
Like the POPs, the COPs also serve to inhibit the maturation and secretion of IL1 beta. However, they achieve this via binding to pro-caspase-1 via CARDCARD interaction and thereby preventing its autocatalytic processing and
activation. Several mammalian COPs have been identified including ICEBERG,
Pseudo-ICE, COP, and INCA. ICEBERG, COP, and INCA all map to
chromosome 11q22, which is the same region where the Pro-caspase-1 gene is
located along with the genes for caspases 4, and 5, which also function in
inflammatory pathways. Therefore, COP proteins are generally believed to have
arisen from gene duplication.
All of the CARD-only proteins exhibit high sequence homology with the
CARD domain of caspase-1, and are generally expressed in the same tissues as
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caspase-1. Furthermore, they have each been demonstrated to bind to the
CARD-containing pro-domain of caspase-1 and this interaction has been
correlated with a decrease in the autoprocessing of caspase-1 as well as
inhibition of IL-1 beta secretion. Interestingly, in addition to their ability to interact
with caspase-1, many of the CARD-only proteins also exhibit the ability to selfassociate as well as bind to one another.
The first CARD-only protein to be identified and characterized was
ICEBERG. ICEBERG is primarily expressed in cardiac and placental tissues,
and is 52% identical to the CARD of caspase-1. It is transcriptionally upregulated
in response to stimulation with the inflammatory cytokine TNF-alpha, as well as
with the bacterial component lipopolysaccharide (LPS) in monocytic and
epithelial cells (Druilhe, 2001,Humke, 2000). Pseudo-ICE is 97% identical to the
pro-domain of caspase-1, and exhibits a near identical tissue expression profile.
Therefore, it is postulated that these two proteins may be under the same
transcriptional regulation. In addition to its interaction with caspase-1 and other
CARD-only proteins, Pseudo-ICE has the capability of interacting with the
caspase-1 activating protein RIP2. Furthermore, Pseudo-ICE is unique among
the COPs in its ability to also function as a potent activator of NF-kB (Druilhe,
2001). COP exhibits 97% identity with the CARD domain of caspase-1, and is
also capable of interacting with RIP2 in addition to caspase-1 (Lee, 2001). INCA,
the most recently discovered CARD only protein, is 81% identical to the CARD
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domain of caspae-1, and is upregulated in response to IFN-gamma, but not LPS
or TNF-alpha (Lamkanfi, 2004).
In addition to the CARD-only proteins, caspase-12 has also been
identified as a modulator of IL-1 beta secretion. Caspase-12 gene ablation
studies have demonstrated a resistance to sepsis and an increase in the capacity
of the immune system to clear pathogenic bacteria. Furthermore, caspase-12 is
able to bind to caspase-1 and prevent its activation, and by extension the
downstream processing of IL-1 beta independent of its enzymatic activity (Saleh
M, 2006). This data suggests that caspase-12 may also function as a dominant
negative inhibitor of inflammasome activation.
In addition to the PYRIN-only proteins and the CARD only proteins, there
is an additional modulator of inflammasome activity called Pyrin. Pyrin is the
product of the MEFV gene, which is located on chromosome 16 and was
identified as the cause of the most common autoinflammatory disorder known as
Familial Mediterranean Fever (FMF) (Bernot A, 1997). FMF is a genetically
recessive disease characterized by recurrent, self-limiting fevers, which are of
short duration. It is predominantly seen in four populations: non-Ashkenazi Jews,
Turks, Armenians, and Arabs. Several physical and environmental stimuli have
been identified as triggers for the recurrent fevers including, emotional stress,
high-fat meals, infections, menstrual cycle, cold temperatures, and some drugs.
Clinical manifestations include a fever, which lasts for 12-72 hours, and then
resolves spontaneously. In addition, involvement of the joints, abdomen, chest,
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skin, and kidneys may also be observed. The most severe clinical complication
is Type AA amyloidosis, which is usually observed in the kidneys in the form of
chronic nephrotic syndrome. Currently, colchicine is the primary choice for
treatment (Fonnesu C, 2008).
Structurally, Pyrin is 781 amino acids long, and consists of multiple
domains. It has an N-terminal Pyrin domain, a zinc finger domain, a Coiled Coil,
domain and a B30.2 domain at its C-terminus. Interestingly, it is the B30.2
domain where the majority of the mutations associated with FMF occur.
Functionally, it is believed that Pyrin as an inhibitor of inflammasome activation
based upon the phenotype of FMF patients. Initial studies with Pyrin
demonstrated that it could interact and modulate the functions of ASC. However,
since then, studies have shown that it can also interact with other inflammasome
components including NLRP3 and caspase-1. As a result, inflammasome
modulation by Pyrin is complex and multi-faceted.
The interaction between Pyrin and ASC was first established by the
Gumucio laboratory. Using a yeast two-hybrid screen they identified ASC as an
interaction partner for Pyrin. Further analysis demonstrated that while Pyrin
localized diffusely in the cytoplasm when overexpressed alone, upon coexpression with ASC, it was recruited to the characteristic ASC ‘specks’. This
interaction was found to be mediated by the Pyrins N-terminal PYD.
Functionally, this group first explored the role of Pyrin in ASC-mediated
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apoptosis. They discovered that co-expression of Pyrin with ASC attenuated
ASC-mediated apoptosis (Richards, 2001).
With regard to its impact on inflammasome function, it has been
demonstrated that Pyrin exhibits both inhibitory and activating properties. The
inhibitory capacity of Pyrin was first demonstrated by Chae et al, through the
generation of mice, which expressed a truncated form of Pyrin lacking the B30.2
domain. Upon treatment with lipopolysaccharide, these mice exhibited elevated
fever and increased lethality over control. In accordance with this, macrophages
from these mice exhibited elevated levels of caspase-1 activation and IL-1 beta
secretion following stimulation with LPS. Furthermore, this group determined
that full-length Pyrin competes with caspase-1 for binding with ASC, which
results in a decrease in caspase-1 activation (Chae, 2003). Interestingly,
subsequent studies demonstrated that a direct interaction between Pyrin and
caspase-1 occurs independent of ASC. Specifically, the B30.2 domain of Pyrin
was shown to interact with catalytic p10 and p20 subunits of caspase-1. In
addition, knock-down of Pyrin in monocytic cells resulted in an increase in IL1beta secretion in response to pathogenic challenge, whereas overexpression of
the B30.2 domain resulted in an inhibition of IL-1beta, which further indicates a
suppressive role for Pyrin in inflammasome activation (Chae, 2006,Papin S,
2007). Conversely, other research groups have shown Pyrin to function as an
inflammasome activator. First, an increase in IL-1 beta secretion was observed
in response to increasing concentrations of Pyrin in a reconstituted
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inflammasome model (Stehlik, 2003b). Intriguingly, this increase was
independent of ASC. Furthermore, knock-down of Pyrin in both the monocytic
cell line and PBMCs resulted in a decrease in IL-1 beta secretion in response to
LPS (Seshadri S, 2007).
Intriguingly, not only does Pyrin’s interaction with caspase-1 influence
inflammasome activation, but caspase-1 can impact Pyrin’s functions as well. It
has been recently demonstrated that Pyrin not only binds to caspase-1, but it is
also a substrate and is cleaved at aspartic acid residue 330. The N-terminal
cleavage product of Pyrin generated by caspase-1 cleavage subsequently
activates NF-kB. The N330 cleavage product achieves this by mediating the
translocation of the p65 subunit to the nucleus as well as causing calpainmediated degradation of IkB-alpha (Chae JJ, 2008).
In the past year, a role for Pyrin in other cellular processes has emerged.
First, Pyrin was found to interact with the pro-apoptotic protein Siva. Siva is a p53
target gene that can modulate apoptosis in response to chemotherapy. It is also
capable of interacting with anti-apoptotic Bcl-2 family members and the
cytoplasmic tail of several TNF receptors. The B30.2 domain of Pyrin and exon 1
of Siva are required in order for these proteins to interact. Intriguingly, Pyrin can
recruit Siva to ASC ‘specks’ when all three proteins are expressed. Therefore,
Pyrin may function as a bridging protein that enables cross-talk between the
apoptotic pathways of ASC and Siva (Balci-Peynircioglu B, 2008). In addition,
new evidence has unveiled a potential role for both ASC and Pyrin in the process
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of cell motility. Waite et al demonstrated that both Pyrin and ASC can localize to
the leading edge of motile cells, which was unaffected by FMF-associated
mutations. Furthermore, they both co-localized in areas rich in polymerizing actin
generated by the bacterium Listeria, known as ‘rocket tails’. While ASC was
unable to co-localize with any of the proteins necessary for rocket tail formation,
Pyrin was determined to directly interact with both VASP and Arp3. Furthermore,
both of these proteins could be recruited to ASC specks upon overexpression with
Pyrin (Waite AL, 2009).
The association between inflammation and cancer has been long
established. Many tumors arise in patients suffering from chronic inflammation,
and the inflammatory component of the tumor microenvironment is essential for
the processes of tumor progression and invasion. IL-1beta is a key proinflammatory cytokine, which upon its release, can initiate a host of systemic and
local responses. Current literature has established inflammasome formation as
crucial step in the activation and secretion of IL-1beta, and the adaptor protein
ASC is necessary for its assembly. However, the regulatory mechanisms safeguarding the integrity of this process have not been fully elucidated. Therefore,
in order to gain a better understanding of how ASC modifications can impact IL1beta maturation, these studies will aim to identify novel regulatory mechanisms
that define the circumstances under which ASC participates in inflammasome
complex formation. Overall, this work will aim to provide further insight into the
intricate cellular processes involved in inflammation and their impact on disease.
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Study 1:
Activation of Inflammasomes Requires Intracellular Redistribution of the
Apoptotic Speck-like Protein Containing a Caspase Recruitment Domain
(ASC)
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ABSTRACT
Activation of caspase-1 is essential for the maturation and release of
interleukin (IL)-1β and IL-18, and occurs in multi-protein complexes, referred to
as inflammasomes. The apoptosis-associated speck-like protein containing a
caspase recruitment domain (ASC) is the essential adaptor protein for recruiting
pro-caspase-1 into inflammasomes, and consistently gene ablation of ASC
abolishes caspase-1 activation and secretion of IL-1β and IL-18. However,
distribution of endogenous ASC has not yet been examined in detail. In the
present study we demonstrated that ASC localized primarily to the nucleus in
resting human monocytes macrophages. Upon pathogen infection ASC rapidly
redistributed to the cytosol, followed by assembly of perinuclear aggregates,
containing several inflammasome components, including caspase-1 and Nod-like
receptors (NLRs). Prevention of ASC cytosolic redistribution completely
abolished pathogen induced inflammasome activity, which affirmed that cytosolic
localization of ASC is essential for inflammasome function. Thus, our study
characterized a novel mechanism of inflammasome regulation in host defense.
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INTRODUCTION
Inflammatory reactions in response to pathogen infection are highly
coordinated processes. Leukocytes are recruited to sites of infection where they
become activated and enlist tissue cells to aid with pathogen clearance. This
response is orchestrated by a complex array of soluble mediators, including
locally released cytokines and chemokines, such as macrophage-released
interleukin (IL)-1β and IL-18. Generation of mature IL-1β and IL-18 is regulated
at multiple steps, including transcription, posttranslational processing and
receptor binding [Dinarello 1998]. Processing into the bioactive secreted 17 or
18 kDa forms, is dependent on the proteolytic activity of caspase-1, which itself
becomes activated in molecular platforms, referred to as inflammasomes
[Martinon 2002]. Inflammasomes emerged recently as multi protein complexes
that link recognition of damage-associated molecular patterns (DAMPs) by
members of the Nod-like receptor (NLR)3 family of cytosolic pattern recognition
receptors (PRRs) to the activation of caspase-1 and processing and release of
the pro-inflammatory cytokines IL-1β and IL-18 [Franchi 2006,Mariathasan
2007,Martinon 2007,Ogura 2006,Stehlik 2007a,Ting 2006]. Core inflammasome
proteins therefore include, NLRs, the pyrin domain (PYD) and caspase
recruitment domain (CARD)-containing adaptor protein apoptotic speck-like
protein containing a CARD (ASC), and caspase-1 [Agostini 2004,Martinon 2002].
The inflammasome-initiating event is recognition of intracellular DAMPs derived
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from pathogens (PAMPs) or host (danger or stress signals) by a cytosolic NLR.
Thus, inflammasomes are assumed to form in the cytosol of phagocytic cells,
such as monocytes and macrophages. NLRs undergo ATP-dependent
oligomerization in response to DAMP recognition, and recruit ASC by PYD-PYD
interaction [Duncan 2007,Faustin 2007]. Subsequently, caspase-1 is recruited
through the CARD of ASC, which is essential for its activation [Srinivasula
2002,Stehlik 2003]. Consistently, macrophages deficient in ASC are impaired in
their ability to activate caspase-1 in response to infection and tissue damage,
emphasizing its central role for the activation of inflammatory caspases
[Mariathasan 2004,Yamamoto 2004].
NLRP3 (Cryopyrin) is activated by Gram positive bacteria and multiple
DAMPs including MDP, bacterial and viral RNA, toxins that cause a decrease in
intracellular potassium levels, genomic DNA, irritants, such as trinitrochlorobenzene and dinitro-1-fluorobenzene and reactive oxygen species, as well
as uric acid and calcium pyrophosphate crystals [Dostert 2008,Kanneganti
2006b,Mariathasan 2006,Martinon 2004,Muruve 2008,Sutterwala
2006,Watanabe 2007]. NLRP3 also functions in concert with P2X7 receptors
recognizing extracellular ATP [Kanneganti 2006b,Mariathasan 2006]. Due to the
central role of IL-1β and IL-18 in regulating inflammation and immunity,
dysregulation of pathways leading to caspase-1 activation and the resulting
uncontrolled secretion of these pro-inflammatory mediators is directly linked to
human inflammatory disorders. Variants of NLRP1 are associated with
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autoimmune diseases that cluster with vitiligo [Jin 2007]. NLRP3-containing
inflammasomes were recently linked to contact hypersensitivity, sunburn,
essential hypertension, gout and pseudogout, and elevated expression of NLRP3
is detected in synovial fluids of RA patients [Feldmeyer 2007,Martinon 2006,Omi
2006,Rosengren 2005,Watanabe 2007]. Furthermore, hereditary mutations in
NLRP3 rendering the protein constitutively active, are directly linked to cryopyrinassociated periodic syndromes (CAPS) [Church 2006,Stojanov 2005]. Mutant
NLRP3 proteins efficiently form complexes with ASC to mediate caspase-1
activation independent of an activating ligand. This finding demonstrates the
potential benefits of controlling the accessibility of ASC for cytosolic NLRs
[Stehlik 2007b]. Several mechanisms have been proposed by which activation of
inflammasomes might be regulated, including single PYD or CARD-containing
proteins and pyrin [Stehlik 2007b]. However, regulation of inflammasomes still
remains largely elusive.
Here we describe a novel regulatory mechanism for inflammasome
assembly. We propose that ASC is sequestered in the nucleus in resting
monocytes and macrophages, and only becomes available to bridge NLRs and
caspase-1 in the cytosol, once macrophages are activated in response to
pathogen infection and cellular stress. Such a mechanism might provide an
additional safety checkpoint to limit spontaneous activation of caspase-1 in
resting cells.
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EXPERIMENTAL PROCEDURES

Cell culture.
THP-1, U-937, HL-60, and HEK293 cells were obtained from the American Type
Culture Collection and maintained as recommended by ATCC. HEK293 cells
were transiently transfected using Polyfect (Qiagen) according to the
manufacturer’s instructions. THP-1 cells were used at low passage numbers and
were regularly tested for mycoplasma infection (MycoAlert, Lonza). THP-1 cells
were transiently transfected using the Nucleofector II (Amaxa) with solution V
and protocol V001 using two ASC-specific siRNAs targeting the 3’UTR and
nucleotides 474-492 of the ASC ORF [Stehlik 2002]. THP-1 cells were seeded
into collagen I (5 µg/cm2)-coated glass cover slips and differentiated into
adherent macrophages by overnight culture in medium supplemented with 15
ng/ml of phorbol 12-myristate 13-acetate (PMA) and further cultured for 2 days.
Where indicated, cells were treated with 2 µg/ml of E. coli total RNA (Ambion), or
2x105 cfu/ml of heat killed Legionella pneumophila (HKL) or Staphylococcus
aureus (HKSA) (InvivoGen).

Isolation of primary monocytes from human peripheral blood.
Human monocytes were isolated by Ficoll-Hypaque centrifugation (Sigma) from
heparanized blood. Mononuclear cells were removed, washed and resuspended
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in serum-free DMEM and isolated by adherence to plastic dishes. Adherent
monocytes were washed, incubated in complete RPMI 1640 media overnight in
glass chamber slide, and were left untreated or treated with 2 µg/ml of E. coli
total RNA (Ambion). Macrophages were obtained by culture of adherent
monocytes on collagen type I (5 µg/cm2)-coated glass cover slips for 7 days in
medium containing 20% FBS. Alternatively, monocytes were isolated from
PBMCs by countercurrent centrifugal elutriation in the presence of 10 µg/ml
polymyxin B sulfate using a JE-6B rotor (Beckman Coulter).

Expression plasmids.
The nuclear localization sequence (NLS) from the SV40 large T antigen
(DPKKKRKV) was utilized to generate a 3xNLS-ASC fusion protein with RFP
epitope tags in pcDNA3 (Invitrogen) and pMSCV-puro (Clontech) expression
vectors [Lanford 1986]. 3 silent point mutations were introduced in the siRNA
recognition sequence (Quick-change, Stratagene) to prevent siRNA-mediated
degradation of ASC and NLS-ASC. Authenticity of all plasmids was confirmed by
sequencing. All other plasmids have been previously described [Dorfleutner
2007a].

Retroviral infections.
293GP2 cells (Clontech) were transiently transfected with RFP-tagged ASC,
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NLS-ASC, empty pMSCV-puro, or GFP-ASC in modified pMSCV-puro
expression vectors (Clontech) or pRNATin-H1.4 (Genscript), in combination with
a VSV-G-encoding expression plasmid to produce a pseudo-typed recombinant
retrovirus. 5x 105 THP-1 cells were infected by spinoculation in the presence of
6 µg/ml polybrene (Sigma) at 32°C. Stable cells were selected 72 hours post
infection with 3 µg/ml puromycin or 400 µg/ml hygromycin for 14 days.
Expression of ASC and NLS-ASC was verified in pooled cell populations by
immunoblot, and knock-down of ASC was verified by immunoblot in cells sorted
by FACS for cGFP expression.

Generation of shRNA plasmids.
shRNA expression constructs were generated by inserting double stranded
oligonucleotides into the MluI and XhoI sites of pRNATin-H1.4 (Genscript)
downstream of the RNA polymerase III H1 promoter. Stable knock down of ASC
in THP-1 cells was achieved by infection with a VSV-G-pseudotyped retrovirus
encoding an shRNA targeting ASC (targeting sequence gctcttcagtttcacacca) or
firefly luciferase (targeting sequence gatttcgagtcgtcttaat) as control by
spinoculation on three consecutive days. Cells were selected in hygromycin (400
µg/ml) for 14 days and sorted by FACS for cGFP expression, which is encoded in
the vector backbone independent from the shRNA.

Immunofluorescence microscopy.
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Adherent cells on collagen I-coated cover slips (5 µg/cm2) were fixed in 3.7%
paraformaldehyde, incubated in 50 mM glycine for 5 minutes and permeabilized
and blocked with 0.5% saponin, 1.5% BSA, 1.5% normal goat serum for 30
minutes. ASC was immunostained with affinity purified monoclonal anti-ASC
antibodies (MBL, 1 µg/ml) directed to the PYD, affinity purified polyclonal
antibodies directed to the CARD from Chemicon, Calbiochem, and Apotech
(1:200), custom raised affinity purified polyclonal antibodies directed to the linker
(CS3; 1: 2,500), and monoclonal anti-myc antibodies (Santa Cruz Biotechnology,
1:350). Caspase-1 was immunostained with a monoclonal anti-caspase-1
antibody from BD Biosciences (1:500) and a polyclonal antibody from Santa Cruz
Biotechnology (1:50); NLRP3 was immunostained with monoclonal anti-NLRP3
antibodies from Abcam (1:50) and Santa Cruz Biotechnology (1:50); and IL-1β
with a polyclonal antibody from Santa Cruz Biotechnology (1:50). Secondary
Alexa Fluor 488, 546, and 647-conjugated antibodies, ToPro-3, DAPI, and
phalloidin were from Molecular Probes. Cells were washed with PBS containing
0.5% saponin, and cover slips were mounted using Fluoromount-G (Southern
Biotech). Suspension cells were fixed and stained as above and adhered to
poly-L-lysine-coated slides using a cytocentrifuge (StatSpin). Images were
acquired by confocal laser scanning microscopy on a Zeiss LSM 510 or LSM 510
Meta, and epifluorescence microscopy on a Nikon TE2000E2 with a 100x oil
immersion objective and image deconvolution.
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Subcellular fractionation.
106 cells were resuspended in hypotonic lysis buffer (10 mM Tris-HCL pH 7.4, 10
mM NaCl, 3 mM MgCl2, 1 mM EDTA, and 1mM EGTA, supplemented with
protease and phosphatase inhibitors), incubated on ice, adjusted to 250 mM
sucrose, and lysed in a Dounce homogenizer. Samples were initially centrifuged
at 4oC at 1,000 xg for 3 minutes to remove any intact cells and then centrifuged
at 4oC at 2,000 xg for 10 minutes to pellet the nuclei. The cytosolic supernatant
was removed, and the nuclear pellet was then washed three times in hyptonic
lysis buffer with the addition of 250 mM sucrose and 0.1% NP-40 and incubated
for 20 minutes on ice. Both fractions were adjusted to 50 mM Tris-HCl pH 7.4,
20 mM NaCl, 3 mM MgCl2, 250 mM sucrose, 0.5% deoxycholate, 0.1% SDS,
0.2% NP-40, and protease and phosphatase inhibitors, and fully solubilized by
brief sonication. 50 µg of protein lysates were separated by SDS-PAGE,
transferred to a PVDF membrane, and probed with anti-ASC antibodies (CS3)
and HRP-conjugated secondary antibodies (Amersham Pharmacia) in
conjunction with an ECL detection system (Pierce). Membranes were stripped
and re-probed with anti-GAPDH (Sigma) and anti-Lamin A (Santa Cruz
Biotechnology) antibodies as control for cytosolic and nuclear fractions,
respectively.
Measurement of secreted IL-1β .
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IL-1β secretion was quantified in culture supernatants using a commercial ELISA
(BD Biosciences) at least in triplicates. Briefly, primary macrophages or THP-1
cells were treated with E. coli total RNA (2 µg/ml), 2x105 cfu/ml of heat killed
Legionella pneumophila (HKLP) or 2x105 cfu/ml of heat killed Staphylococcus
aureus (HKSA) (InvivoGen) in 12-well dishes for 16 hours and the cleared culture
supernatant was analyzed by ELISA. HEK293 cells were grown in collagen Itreated 12-well culture dishes and co-transfected with plasmids encoding mouse
pro-IL-1β, pro-caspase-1, NLRP3R260W, ASC, or NLS-ASC. 24 hours posttransfection, culture media were replaced, collected 36 hours post transfection,
clarified, and IL-1β activated by reconstituted inflammasomes was analyzed by
mouse IL-1β ELISA according to the manufacturer’s protocol [Dorfleutner
2007a,Dorfleutner 2007b,Stehlik 2003].
Statistical methods.
A standard two-tailed t-test was used for statistical analysis; P values of 0.05 or
less were considered significant.
RESULTS

Nuclear localization of ASC in resting monocytes
ASC has previously been shown to localize diffusely throughout the cell (Fig. 1A,
upper panel), as well as to form characteristic aggregates (Fig. 1A, middle panel)
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[Masumoto 1999]. In addition, THP-1 cells stably expressing GFP-ASC,
predominantly exhibited nuclear distribution of GFP-ASC, as determined by
nuclear counter staining (Fig. 1A, lower panel). However, most studies to date
have relied upon over-expression of ASC. To clarify the localization of ASC and
its implications on the activity of inflammasomes, we studied the subcellular
localization of endogenous ASC in monocytes and macrophages, where it is
essential for inflammasome function [Mariathasan 2004,Yamamoto 2004]. First
we examined ASC subcellular localization by immunofluorescence microscopy in
primary human peripheral blood monocytes (Fig. 1B, 1st panel) and a panel of
human monocytic cell lines, including HL-60 (Fig. 1B, 2nd panel), U-937 (Fig. 1B,
3rd panel) and THP-1 cells (Fig. 1B, 4th panel). Without exception, all cells
showed nuclear localization of ASC, emphasizing that endogenous ASC
localized to the nucleus in monocytes. Immunostaining was performed with
different anti-ASC antibodies, including commercially available mouse
monoclonal (U-937) or rabbit polyclonal (HL-60) antibodies or a custom raised
rabbit polyclonal anti-ASC antibody (THP-1 and primary monocytes). To further
demonstrate specificity of nuclear ASC staining, we performed an ASC peptide
competition assay. The custom raised polyclonal anti-ASC antibody was
incubated with a 1000-fold molar excess of the peptide used initially for
immunization, before being employed in immunostaining of THP-1 cells (Fig. 1B,
5th panel). Peptide competition completely abrogated nuclear ASC staining in
THP-1 cells. These ASC antibodies are highly specificity for ASC without cross56

reactivity by western blot of THP-1 cell lysates (Fig. 1C) and HEK293 cells that
were transfected with myc-tagged ASC or control plasmid (Fig. 1D).

Stimulation-dependent translocation of ASC from the nucleus to the
cytosol in monocytes
Inflammasomes form in response to pathogen and PAMP recognition, and we
therefore examined the localization of ASC in primary monocytes and THP-1
monocytes after treatment with E. coli total RNA for 30 minutes, which
specifically activates an NLRP3-dependent inflammasome response [Kanneganti
2006a,Kanneganti 2006b]. Contrary to the nuclear localization of ASC observed
in resting monocytes (Fig. 1B), immunofluorescence staining of E. coli total RNA
activated cells revealed a cytosolic distribution of ASC in primary as well as THP1 monocytes (Fig. 2A). To confirm this observation, proteins from resting and E.
coli total RNA-treated THP-1 cells were fractionated into nuclear and cytosolic
fractions and immunoblotted with ASC-specific antibodies. To control
fractionation efficiency, membranes were stripped and re-probed with antibodies
specific for the cytosolic GAPDH and the nuclear Lamin A proteins, respectively
(Fig. 2B). Although the control proteins clearly indicated that the fractionation
procedure was highly efficient, ASC was also seen in the cytosol in resting cells,
which was not visible by immunofluorescence microscopy and was likely caused
by nuclear leakage of the small ASC protein during aqueous fractionation, which
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is a well-acknowledged problem for small proteins [Gordon 1981,Paine 1983].
ASC is only 22 kDa in size, and therefore retaining more than 50% of ASC inside
the nucleus during fractionation further confirms its predominantly nuclear
localization in resting monocytes, and that ASC redistributes from the nucleus to
the cytosol following exposure to E. coli total RNA. Therefore, we conclude that
PAMPs are capable of inducing translocation of ASC from the nucleus to the
cytosol in monocytes.

Formation of cytosolic ASC aggregates in response to inflammatory
activation of macrophages
Monocytes infiltrate sites of infection and differentiate into inflammatory
macrophages to aid pathogen clearance and homeostasis. Therefore, we next
examined distribution of ASC in primary macrophages, which were either resting
or activated with E. coli total RNA for 6 hours. Similar to monocytes, resting
macrophages displayed primarily nuclear ASC (Fig. 3A, upper panel), while the
majority of E. coli total RNA-activated macrophages showed the characteristic
ASC-containing perinuclear aggregates (Fig. 3A, lower panel), reminiscent of the
structures that were observed upon ASC overexpression (Fig. 1A, middle panel).
To prove that THP-1 cells can be used as a model for inflammasome studies,
ASC-containing aggregates were also assessed in PMA-differentiated THP-1
macrophages by immunostaining before and after activation with E. coli total
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RNA for 6 hours. As observed for primary macrophages, differentiated resting
THP-1 macrophages showed nuclear ASC (Fig. 3B, upper panel) and activation
with E. coli total RNA for 6 hours caused ASC to form cytosolic aggregates (Fig.
3B, middle panel). To demonstrate specificity for the staining of ASC-containing
aggregates, we also performed a peptide competition assay with the custom
rabbit polyclonal anti-ASC antibody, as shown in figure 1B. Peptide competition
completely abrogated any ASC aggregate staining (Fig. 3B, lower panel), which
confirmed the specificity of the ASC antibody for ASC aggregate staining. Since
ASC is the only known adaptor protein for inflammasome mediated caspase-1
activation, ASC-containing aggregate formation may be crucial for caspase-1
activation and consequently, macrophages from ASC-/- mice fail to activate
caspase-1 in response to Gram-positive and Gram-negative bacteria
[Mariathasan 2004]. Gram-positive but not Gram-negative pathogens are able to
induce inflammasomes in an ASC and NLRP3-dependent manner [Kanneganti
2007,Kanneganti 2006b,Mariathasan 2004,Mariathasan 2006]. To demonstrate
that the observed response is not only due to a PAMP, THP-1 derived
macrophages were infected with heat-killed Gram-positive Staphylococcus
aureus (HKSA) for 4 hours, followed by immunofluorescence staining of ASC.
Concomitant with NLRP3-dependent pathogen recognition and subsequent
inflammasome formation and activation, Gram-positive pathogens also caused
ASC aggregate formation (Fig. 3C, upper panel). Additionally, Gram-negative
Legionella pneumophilia (HKLP) for which no specific NLR has been defined yet,
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also caused ASC-containing aggregates (Fig. 3C, lower panel). This data
suggest that inflammasomes potentially activated by other NLRs are able to
trigger ASC aggregate formation, which is therefore not limited to NLRP3.

ASC aggregation is an early response of macrophage activation
Maturation and release of IL-1β by macrophages occurs rapidly in response to
infections. We therefore wanted to investigate a time course of ASC nuclear to
cytosolic redistribution and formation of aggregates in response to stimulation
with E. coli RNA. THP-1 cells were kept untreated or treated with E. coli total
RNA for 0.5, 1, 6 and 24 hours, and distribution of ASC was analyzed in these
cells by immunofluorescence (Fig. 4). Within 30 minutes of E. coli total RNA
treatment the majority of cells displayed ASC redistribution from the nucleus to
the cytosol, with some cells showing diffuse nuclear and cytosolic distribution.
After 1 hour, ASC was cytosolic, with aggregate formation visible in some cells.
Longer exposure to E. coli total RNA induced ASC-containing aggregates in the
majority of cells and further increased the size of these aggregates, which are
still present after 24+ hours of activation, without any signs of toxicity.
Significantly, duration of ASC-containing aggregates required the persistent
presence of E. coli total RNA (or LPS or heat killed pathogens, data not shown),
since wash-out of E. coli RNA after 6 hours of exposure caused a dissociation of
aggregates with some nuclear accumulation of ASC visible after 12 hours (Fig. 4,
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bottom panel). This observation suggested that ASC redistribution and
aggregation is reversible, which could indicate a function in host response to
infections and other stress situations.

Caspase-1 and NLRP3 co-localize with ASC to aggregates
Inflammasomes are multi protein complexes consisting of at least an NLR
protein, ASC, and caspase-1 [Martinon 2002]. Over-expression studies
suggested that many ASC-interacting proteins co-localize to aggregates of overexpressed ASC. We find that, in response to pathogen infection, macrophages
display a 4 to 6 µm ring shaped perinuclear structure, which contains
endogenous ASC (Fig. 5A). Upon compiling of 20 images along the z-axis, a 3
dimensional image revealed that this structure is spherical with a hollow center
(Fig. 5B). To characterize localization of additional inflammasome proteins,
immunostaining for caspase-1 and NLRP3 was performed. In resting THP-1
macrophages caspase-1 localized to the nucleus and to small vesicular
structures in the cytosol (Fig. 5C, upper panel), while E. coli total RNA-activation
caused partial localization of caspase-1 to perinuclear aggregates (Fig. 5C, lower
panel). Co-staining of caspase-1 with ASC showed that both proteins displayed
a similar pattern inside the nucleus in resting THP-1 macrophages (Fig. 5D,
upper panel), and that both proteins co-localize to aggregates in E. coli total
RNA-treated cells (Fig. 5D, lower panel). NLRP3R260W is a constitutively active
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CAPS-linked mutant, causing ligand-independent recruitment of ASC and
caspase-1 [Dowds 2004,Yu 2006]. Co-expression of ASC, pro-caspase-1 and
NLRP3R260W in HEK293 cells, caused formation of ASC-containing aggregates
and co-localization of all three inflammasome proteins in these aggregates (Fig.
5E). We did not obtain specific staining for endogenous NLRP3 in resting cells,
which is in agreement with reports that NLRP3 is inducibly expressed in
response to pro-inflammatory agents [O'Connor 2003]. Nevertheless, in E. coli
total RNA-treated cells, NLRP3 was present in ASC-containing aggregates in
some cells, as well as in punctate structures throughout the cytosol (Fig. 5F).
Overall, these results demonstrate that macrophages recruit NLRs, ASC and
caspase-1 into perinuclear aggregates in response to pathogen infection,
providing the intriguing possibility that these aggregates may represent
inflammasomes.

ASC aggregate-dependent maturation of IL-1β
To test the hypothesis that these aggregates may represent inflammasomes, we
determined IL-1β secretion in cell culture supernatants by ELISA under
conditions that cause ASC-containing aggregate formation in E. coli total RNA
treated macrophages (Fig. 6A). Secreted IL-1β was significantly elevated in
macrophages after E. coli total RNA treatment over untreated control. To directly
link elevated levels of released IL-1β to inflammasomes, we generated stable
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THP-1 cells with an shRNA-mediated knock-down of ASC. shRNA ASC or
control THP-1 cells were treated with E. coli total RNA, HKLP or HKSA that
cause ASC aggregate formation and secreted IL-1β levels were determined by
ELISA in culture supernatants. While control cells show a significant increase in
secreted IL-1β, ASC knock-down cells are completely impaired in the release of
IL-1β into culture supernatants (Fig. 6B). The efficiency of ASC knock-down was
assessed by immunoblot in cleared lysates of control and ASC knock-down cells
(Fig. 6B). Furthermore, wild type cells (GFP negative) form ASC-containing
aggregates, as determined by immunofluorescence analysis, whereas ASC
knock-down THP-1 cells (GFP-positive) do not show ASC-containing aggregates
following E. coli total RNA treatment, further demonstrating the link between
ASC-containing aggregates and IL-1β release (Fig. 6C).

Redistribution of ASC to the cytosol is essential for inflammasome activity
The significance of cytosolic redistribution of ASC is further emphasized by the
cytosolic distribution of the inflammasome target, pro-IL-1β, in response to E. coli
total RNA treatment of THP-1 cells. Consistent with previous reports that show
upregulated pro-IL-1β expression in response to infection [Mileno 1995], no IL-1β
staining was observed in resting cells (Fig. 7A, upper panel), while cytosolic
distribution is present in activated cells (Fig. 7A, lower panel). To further test the
hypothesis that ASC cytosolic redistribution is essential for inflammasome
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formation and activity, we altered its intracellular localization. A constitutive
nuclear ASC was generated by in-frame fusion of ASC with three tandem repeats
of the strong consensus nuclear localization sequence (NLS)3 derived from the
SV40 large T antigen, which has frequently been employed to target proteins to
the nucleus [Lanford 1986,Screaton 2003]. Three copies of the NLS were used
to ensure efficient nuclear retention of ASC even after inflammatory stimulation.
We chose this approach over mutational analysis because both death domain
folds of ASC require correct folding to retain full adaptor function and even point
mutations could disrupt the overall structure and function of ASC, which may lead
to a wrong interpretation of results, while NH2 terminal fusion of ASC generally
does not alter its function (data not shown). To confirm the nuclear localization of
this ASC fusion protein (NLS-ASC), HEK293 cells were transfected and
localization was compared to wildtype ASC. As shown in Fig. 1A,
overexpression of wildtype ASC results in either nuclear/cytosolic localization, or
preferentially the formation of perinuclear aggregates (Fig. 1A and 7B, upper
panel). In contrast, transfection of NLS-ASC showed exclusively nuclear
localization, suggesting that the fusion of a strong NLS to ASC was sufficient to
retain it inside the nucleus (Fig. 7B, lower panel). To determine the functional
significance of nuclear versus cytosolic distribution of ASC, we utilized an
inflammasome reconstitution assay in HEK293 cells, which are deficient in
endogenous inflammasomes, but are able to produces mature IL-1β upon
reconstitution of inflammasomes [Dorfleutner 2007a,Dorfleutner 2007b,Stehlik
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2003]. We reconstituted inflammasomes by transient transfection of procaspase-1, pro-IL-1β, NLRP3R260W, and either ASC or NLS-ASC, and determined
the amount of secreted IL-1β in culture supernatants. While inflammasomes
containing wild type ASC caused processing and release of IL-1β,
inflammasomes restored with NLS-ASC were not capable of secreting IL-1β into
culture supernatants above baseline level (Fig. 7C). Total cell lysates were used
to verify expression of all transfected inflammasome proteins by immunoblotting
(Fig. 7C). To directly assess inflammasome activity in macrophages, we infected
THP-1 cells with recombinant retroviruses encoding ASC or NLS-ASC, which is
not targeted by the siRNA, because we introduced three silent point mutations in
the siRNA recognition sequence. We used an RFP fusion to conveniently
distinguish between endogenous and ectopic ASC by the increased molecular
weight, and chose stable pooled cell populations with expression levels
comparable to endogenous ASC, as analyzed by immunoblotting (Fig. 7D, right
upper panel). Endogenous ASC was knocked down by two pooled siRNAs, and
was confirmed by immunoblotting (Fig. 7D, right lower panel). Next, IL-1β
release was measured in response to E. coli total RNA treatment. While
activation of control cells strongly promoted release of IL-1β, knockdown of
endogenous ASC from wild type cells efficiently reduced IL-1β release, which
was restored in RFP-ASC expressing cells. In contrast, expression of NLS-ASC
in ASC knockdown cells failed to restore secretion of IL-1β above the level
observed in stimulated ASC knockdown cells (Fig. 7D, left panel). These data
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confirmed that nuclear export of ASC is essential for inflammasome activity,
since nuclear retention of ASC completely impaired inflammasome-mediated IL1β release.
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DISCUSSION
In this report we studied the intracellular distribution of the central inflammasome
adapter ASC and provide evidence that inducible redistribution of ASC from the
nucleus to the cytosol is essential for inflammasome function. While
inflammasomes are biochemically characterized, no detailed studies have been
undertaken to visualize endogenous inflammasomes. Over-expression studies
result predominantly in the formation of aggregates, referred to as specks
[Fernandes-Alnemri 2007,Masumoto 1999]. However, ASC-containing
aggregates were believed to represent artificial results driven by enforced overexpression causing self-aggregation of ASC. We observed nuclear localization
of ASC in monocytes and macrophages with several anti-ASC antibodies
recognizing different epitopes, thus excluding epitope masking as an explanation
for our results.
Nuclear localization of ASC, however, cannot explain its essential function
as an adaptor protein for inflammasome-mediated caspase-1 activation, which
occurs in the cytosol of cells [Brough 2007]. We find cytosolic accumulation of
ASC in response to purified PAMPs as well as heat-killed Gram negative and
Gram positive bacteria, suggesting that this response is part of the host defense
to clear pathogens. Redistribution of ASC from the nucleus to the cytosol can be
observed as early as 30 minutes post-stimulation, while longer stimulation
caused the aggregation of ASC into structures that resembled the specks
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observed by enforced over-expression of ASC, including the perinuclear
localization and the spherical morphology with a hollow center. Additionally,
ASC-containing aggregates appear to grow in size over time. To our knowledge,
we provide the first evidence of host defense-mediated assembly of ASCcontaining aggregates in macrophages. We propose that inducible redistribution
of ASC from the nucleus to the cytosol is required for its interaction with activated
NLRs to form caspase-1-activating inflammasomes. ASC-containing aggregates
not only assembled in response to the NLRP3 ligands bacterial RNA, and
S.aureus, but also in response to Gram negative bacteria and other PAMPs (data
not shown), suggesting that other NLRs also aggregate with ASC, consistent with
the requirement of ASC for inflammasome-mediated activation of caspase-1 in
response to Gram negative and Gram positive pathogens [Mariathasan 2004].
Caspase-1 activation can induce pyroptosis, which is a form of
programmed cell death associated with antimicrobial responses in inflammation,
which results in osmotic lysis of cells [Fink 2006]. A caspase-1 and GFP-ASC
containing protein complex termed pyroptosome has recently been proposed to
facilitate pyroptosis through self-oligomerization of ASC in response to potassium
depletion [Fernandes-Alnemri 2007]. However, other reports did not find a link
between ASC and pyroptosis [Suzuki 2007]. NLRP3 and ASC have also been
implicated in caspase-1 and IL-1β-independent pyronecrosis [Willingham 2007].
Thus, the role of ASC and caspase-1 containing complexes in pyroptosis and
pyronecrosis is still unclear. We propose that ASC may participate in different
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multi-protein complexes that facilitate either effective IL-1β secretion
(inflammasomes) or cell death (pyroptosomes, pyronecrosomes). ASC has also
been shown to localize to mitochondria in response to genotoxic insult, which is
essential to facilitate p53-mediated Bax translocation to mitochondria and
subsequently apoptosis in fibroblasts, hence participating in yet another signaling
complex [Ohtsuka 2004]. This complex could be specific to DNA damage in
fibroblasts.
Although we do not understand yet what the determining factor for such
different outcomes is in macrophages, we noticed significant differences in the
appearance and functional properties of these multi-protein complexes.
Endogenous ASC aggregates in response to NLR activation are 4-6 µm
compared to the smaller (~1 µm) and more compact aggregates (specks) caused
by over expression of ASC and potassium depletion [Fernandes-Alnemri 2007],
or that form in response to cytotoxic treatment of macrophages (data not shown).
In spite of aggregate formation, cells do not show any sign of cell death for at
least 48 hours, which is in sharp contrast to the rapid cell death in response to
the formation of GFP-ASC-containing pyroptosomes [Fernandes-Alnemri 2007].
ASC-containing aggregates are reversible, which is contrary to structures
causing cell death, because removal of the activating ligand by washing in
culture medium resulted in dissociation of ASC-containing aggregates and
diffuse cytoplasmic and even nuclear re-distribution of ASC. Furthermore, these
complexes contain caspase-1 and NLRs, though caspase-1 co-localization with
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ASC was more frequently detectable than co-localization with NLRP3.
Ultrastructural studies performed by electron microscopy and molecular
approaches investigating the release of IL-1β from activated monocytes also did
not find any signs of cell death during IL-1β release, and suggested a secretory
mechanism that does not involve apoptosis, cell death, or surface membrane
lysis [Rubartelli 1990,Singer 1995].
Since conditions that induced ASC aggregates also caused maturation of
IL-1β and IL-18, these ASC-containing aggregates could potentially represent
inflammasomes. Inflammasomes have been biochemically characterized as
large, inducible protein aggregates, consisting of an NLR, ASC, and procaspase-1 [Martinon 2002]. Other proteins can be associated with some
inflammasomes. Thus, ASC-containing aggregates might provide a scaffold for
inflammasome proteins to interact and to promote caspase-1 activation.
Activation of NLRs causes their unfolding and NTP-mediated oligomerization,
resulting in pentameric and heptameric aggregates in vitro [Faustin 2007]. Thus,
it is feasible that ASC aggregates might denote higher order oligomeric
structures of NLRs, as indicated by their larger size. Alternatively, larger
aggregates might assemble in vivo, because incorporation of accessory proteins
is lacking by in vitro reconstitution. Recombinant NLRP1 pentamers or
heptamers are about 20 nm in diameter [Faustin 2007], while most endogenous
ASC aggregates are 4-6 µm. Adherence of cells is not required for ASC-
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containing aggregates, as we observed it also in activated monocytes (data not
shown).
Fusion of proteins with nuclear localization sequences has been widely
employed to prevent redistribution of proteins with nuclear and cytosolic
localization. We employed this approach to sequester ASC inside the nucleus of
macrophages to prevent ASC export. Nuclear ASC completely abrogated
endogenous as well as reconstituted inflammasome-mediated maturation of IL1β, directly demonstrating the requirement for ASC redistribution for
inflammasome activity. We also noted co-localization of ASC with pro-caspase-1
in the nucleus of resting macrophages, suggesting that both proteins might preassemble in the nucleus of cells even before oligomerization with activated NLRs
in the cytosol. In addition, both also localized to ASC-containing aggregates in
activated macrophages. Different localizations have been reported for caspases1, including cytosolic, vesicular, nuclear, as well as the inner and outer face of
plasma membranes, which likely reflect different activation states of cells [Mao
1998,Nakagawara 1997,Shikama 2001,Singer 1995]. Moreover, caspase-1 is
responsible for its own secretion alongside its cytokine substrates [Keller
2008,Martinon 2002]. Nuclear caspase-1 has been suggested to mediate
apoptosis in tumor cells, but we did not observe apoptosis in macrophages, in
spite of its nuclear localization [Mao 1998]. This is supported by our observation
that resting macrophages showed nuclear caspase-1, while a cytosolic to nuclear

71

translocation occurs in neuroblastomas undergoing apoptosis [Nakagawara
1997].
Whether ASC is only physically separated inside the nucleus to prevent its
spontaneous recruitment to NLRs and subsequent secretion of inflammatory
cytokines, or whether ASC performs inflammasome-independent functions inside
the nucleus, warrants further investigations. The related protein FADD, which
links death receptors to caspase-8 activation in the cytosol, has been recently
shown to localize to the nucleus in non-apoptotic cells, and its export is required
for caspases-8 activation [Gomez-Angelats 2003,Screaton 2003]. Nuclear and
cytosolic FADD is involved in genome surveillance and death receptor-mediated
apoptosis, respectively. Nuclear FADD further regulates mitosis and proliferation
of T-cells [Alappat 2005]. Likewise cytosolic TRADD, another death domain foldcontaining adapter protein, participates in death receptor-mediated apoptosis,
while nuclear localized TRADD mediates PML and p53-mediated apoptosis and
interacts with STAT1-α to modulate IFN-γ signaling in macrophages [Morgan
2002,Wesemann 2004].
Recent evidence suggested a crosstalk between Toll like receptors
(TLRs)3 and the NLR system during host defense. Pathogen recognition by
TLRs is required for up-regulation of inflammasome components and substrates,
while subsequently the NLR system is essential for processing of the cytokine
precursors. Our data indicate another layer of complexity in the regulation of IL72

1β and IL-18 maturation, where pathogen recognition initially triggers nuclear to
cytosolic redistribution of the NLR adaptor ASC, which then links NLRs to
caspase-1 activation in inflammasomes (Fig. 8). While the molecular mechanism
of ASC cytosolic redistribution is currently elusive, it potentially could be targeted
for prevention of inflammasome-mediated inflammatory cytokine secretion in
patients with periodic fever syndromes and other inflammatory conditions.
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Figure 1. Nuclear localization of ASC.
(A) HEK293 cells were transiently transfected with myc-ASC, fixed, and
immunostained with anti-myc and Alexa Fluor 488-conjugated antibodies, while
GFP-ASC expressing THP-1 cells were fixed and cytospun onto glass slides.
ASC either localized diffusively throughout the cell (upper panel) or into a
perinuclear aggregate (middle panel), while stable expression of GFP-ASC in
THP-1 cells showed nuclear localization (lower panel).
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(B) Subcellular localization of endogenous ASC was examined in primary human
monocytes and several monocytic cell lines. Cells were fixed and ASC was
immunostained with monoclonal antibodies from MBL (monocytes) (1st panel),
and polyclonal antibodies from Chemicon, Calbiochem, and custom raised (HL60, U-937, THP-1) (2nd, 3rd, and 4th panel).
THP-1 cells were also
immunostained in the presence of a 1000x molar excess of the ASC-specific
peptide that is recognized by the CS3 anti-ASC antibody (5th panel). Secondary
Alexa Fluor 488-conjugated antibodies were used in combination with ToPro-3
and Alexa Fluor 546-conjugated phalloidin to counter stain nuclei (DNA) and the
actin cytoskeleton to outline cells, respectively. Images were acquired by laser
scanning confocal microscopy, and the panels from left to right are showing ASC
(green), nucleus (blue), actin (red), and a merged image.
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(C) THP-1 lysates (75 µg) were analyzed by immunoblot using the anti-ASC
antibodies used in immunofluorescence microscopy. An asterisk denotes a
splice form of ASC, which is not recognized by our custom-raised polyclonal antiASC antibody (CS3).
(D) HEK293T cells were either mock transfected or transfected with a myctagged ASC expression construct. Cleared cell lysates were analyzed by
immunoblot using the anti-ASC antibodies used in immunofluorescence
microscopy and anti-myc antibodies (Santa Cruz Biotech) as control. Blots were
also stripped and re-probed for GAPDH to demonstrate equal loading.
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Figure 2. Cytosolic redistribution of ASC in response to inflammatory
stimulation of monocytes.
(A) Subcellular localization of ASC was analyzed by immunofluorescence in
primary monocytes and THP-1 monocytes following treatment with E. coli total
RNA (2 µg/ml) for 30 minutes, using the monoclonal anti-ASC antibody described
in Fig. 1. Images were acquired by laser scanning confocal microscopy. Panels
from left to right are showing ASC (green), nucleus (blue), actin (red), and a
merged image.
(B) Subcellular localization of ASC was determined by subcellular fractionation of
control and E. coli total RNA (2 µg/ml)-activated THP-1 cells. 106 cells were
fractionated by differential centrifugation into nuclear (N) and cytosolic (C)
fractions, and protein lysates (50 µg) were analyzed by immunoblotting with antiASC and HRP-conjugated secondary antibodies. Fractionation efficiency was
controlled by re-probing membranes with anti-GAPDH (cytosolic) and anti-Lamin
A (nuclear) antibodies. *denotes two cross reactive proteins in the cytosolic
fraction following E. coli total RNA treatment.
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Figure 3. Aggregate formation of endogenous ASC in response to
inflammatory stimulation in macrophages. Subcellular localization of ASC
was analyzed by immunofluorescence in primary macrophages (A) and PMAdifferentiated THP-1 macrophages (B,C), using mono- and polyclonal anti-ASC
and Alexa Fluor 488-conjugated secondary antibodies in combination with
ToPro-3 nuclear stain and Alexa Fluor 546 conjugated phalloidin to visualize
actin. Images were acquired by laser scanning confocal microscopy. All panels
show ASC (green), nucleus (blue), actin (red), and a merged image from left to
right.
(A) Primary macrophages, either untreated (upper panel) or E. coli total RNA
treated (2 µg/ml) (lower panel), were immunostained using the CS3 polyclonal
anti-ASC antibody.
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(B) Untreated (upper panel) and E. coli total RNA (2 µg/ml) treated THP-1
macrophages (middle and lower panels) were immunostained using the
polyclonal anti-ASC antibody in the absence (middle panel) or in the presence
(lower panel) of a 1000x molar excess of the ASC-specific peptide (note the loss
of specific ASC aggregate staining in the panel with peptide competition).
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(C) THP-1 macrophages were activated with 2x105 cfu/ml heat killed
Staphylococcus aureus (HKSA) (upper panel) and Legionella pneumophilia
(HKLP) (lower panel), and immunostained with the CS3 polyclonal antibody.
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Figure 4. Aggregation of ASC occurs within one hour of inflammatory
stimulation of macrophages and depends on the continued presence of the
stimulus.
Subcellular localization of ASC in THP-1 macrophages was analyzed by
immunofluorescence following stimulation of cells with E. coli total RNA (2 µg/ml)
for the indicated times. Cells were fixed at 0 minutes, 30 minutes, 1 hour, 6
hours, and 24 hours post-stimulation. In addition, after 6 hours of stimulation,
cells were washed extensively and cultured for additional 12 hours in the
absence of E. coli total RNA. Fixed cells were stained with the polyclonal CS3
anti-ASC, and Alexa Fluor 488-conjugated secondary antibodies. DNA and the
actin cytoskeleton were visualized as above. The panels from left to right are
showing ASC (green), nucleus (blue), actin (red), and a merged image.
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Figure 5. Caspase-1 and NLRP3 co-localize with ASC in aggregates.
All images show PMA-differentiated THP-1 macrophages, except (E), which are
HEK293T cells.
(A) Cells were treated with E. coli total RNA (2 µg/ml) and immunostained with
polyclonal anti-ASC and Alexa Fluor 546-conjugated antibodies (red),
monoclonal anti-β-tubulin and Alexa Fluor 488-conjugated antibodies (green) and
the nuclear stain DAPI (blue). The insert in the lower right half highlights the
ring-shaped ASC-containing aggregate. The scale bar measures 10 µm and 1
µm, respectively.
(B) E. coli total RNA (2 µg/ml)-treated cells were immunostained with polyclonal
anti-ASC and Alexa Fluor 546-conjugated antibodies (red) and DAPI (blue). 20
optical sections at 0.6 µm were captured, deconvoluted and assembled into a 3D
structure, showing xy, yz, and xz views of the aggregate. The scale bar is 10
µm.
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Untreated (upper panel) or E. coli total RNA (2 µg/ml)-treated cells (lower panel)
were fixed and immunostained with (C) polyclonal anti-caspase-1 and
monoclonal β-tubulin and Alexa Fluor 546 and 488-conjugated secondary
antibodies, respectively.
(D) Polyclonal anti-ASC and monoclonal anti-caspase-1 antibodies and Alexa
Fluor 488- and 546-conjugated secondary antibodies, respectively. DNA was
visualized with DAPI, and panels from left to right show (C) caspase-1 (red),
nucleus (blue), β-tubulin (green), and a merged image and (D) ASC (green),
caspase-1 (red), nucleus (blue), and a merged image.
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(E) Flag-tagged ASC, HA-tagged caspase-1 and myc-tagged NLRP3R260W were
transiently transfected into HEK293 cells and immunostained with rabbit antiASC, mouse anti-NLRP3, and rat anti-HA antibodies and Alexa Fluor 546-, 647-,
and 488-conjugated secondary antibodies, respectively, to determine colocalization of all three proteins in transfected cells. Panels from left to right
show ASC (red), NLRP3R260W (blue), caspases-1 (green), phase, and a merged
image.
(F) E. coli total RNA (2 µg/ml)-treated THP-1 macrophages were immunostained
with rabbit anti-ASC and goat anti-NLRP3 antibodies and Alexa Fluor 488- and
546-conjugated secondary antibodies, respectively. Panels from left to right
show ASC (red) and NLRP3 (green) and a merged image.

84

Figure 6. ASC aggregate formation is linked to the maturation of IL-1β.
(A) Normalized culture supernatants from resting and E. coli RNA (2 µg/ml)activated primary human macrophages were analyzed by ELISA for released IL1β. Results represent an average of two independent experiments, and are
presented as fold release compared to untreated macrophages.
(B) Culture supernatants from THP-1 cells stably transfected with either an
shRNA targeting ASC (black bars) or a control shRNA targeting luciferase (gray
bars) and left either untreated, or treated with E. coli RNA (2 µg/ml), HKLP (2x105
cfu/ml) or HKSA (2x105 cfu/ml) were analyzed as above for released IL-1β. Cells
were previously FACS sorted for GFP expression, which is encoded from the
pRNATin-H1.4 (Genscript) shRNA vector backbone. Results represent an
average of three independent experiments, and are presented as pg/ml of
released IL-1β. The insert shows an immunoblot of control shRNA and ASC
shRNA expressing THP-1 cells for ASC and GAPDH as a loading control.
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(C) ASC-containing aggregates were analyzed following treatment with E. coli
total RNA (2 µg/ml) for 6 hours by immunofluorescence in a mixed population of
shRNA ASC transfected cells before FACS sorting for GFP expression of the
ASC shRNA. ASC was immunostained with the polyclonal CS3 antibody, and
images were acquired by laser scanning confocal microscopy. Panel shows from
left to right ASC (red), ASC shRNA (green), nucleus (blue), and a merged image.
Note that the cell on the left side (white arrow) encodes the ASC shRNA, as
indicated by the GFP positive signal and therefore does not form ASC-containing
aggregates, while the cell on the right is GFP negative, thus does not encode the
ASC shRNA and therefore shows aggregated ASC.
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Figure 7. ASC localization to the cytosol is required for inflammasome
formation and efficient IL-1β secretion.
(A) Untreated and E. coli RNA-treated THP-1 macrophages were immunostained
with anti-IL-1β and Alexa Fluor 488-conjugated secondary antibodies. Nuclei
and actin were visualized as above. Panels show from left to right IL-1β (green),
nucleus (blue), actin (red), and a merged image. Images were acquired by laser
scanning confocal microscopy.
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(B) Myc-tagged ASC (upper panel) and myc-tagged NLS-ASC (lower panel) were
transiently transfected into HEK293 cells and immunostained with monoclonal
anti-myc and Alexa Fluor 546-conjugated secondary antibodies. Nuclei and actin
were visualized as above. Panels show from left to right ASC (red), actin
(green), nucleus (blue), and a merged image. Images were acquired by laser
scanning confocal
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(C) Inflammasomes consisting of a constitutively active NLRP3R260W, pro-IL-1β,
pro-caspase-1, and either ASC or NLS-ASC, were transiently reconstituted in
HEK293 cells, as indicated, and inflammasome activity was assayed by
analyzing secreted IL-1β by ELISA. Results represent an average of at least
three independent experiments +/- SD. Cleared and normalized cellular lysates
were analyzed by immunoblot for expression of all transfected inflammasome
components, as indicated.
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(D) THP-1 cells were stably infected with a VSV-G pseudo-typed recombinant
retrovirus encoding either red fluorescent protein (RFP)-fused ASC or RFP-fused
NLS-ASC with expression levels comparable to endogenous ASC. Mockinfected, RFP-ASC, and RFP-NLS-ASC expressing cells were transiently
transfected with two pooled ASC-specific siRNAs to knock-down expression of
endogenous ASC, but not RFP-ASC or RFP-NLS-ASC. Cells were seeded into
fresh wells 24 hours post nucleofection, and where indicated treated with LPS
and E. coli RNA for 12 hours. Secreted IL-1β was determined in culture
supernatants by ELISA and results are presented as pg/ml of 106 cells, and
represent an average of three independent experiments +/- SD. The insert
shows stable expression of RFP-ASC and RFP-NLS-ASC compared to
endogenous ASC in THP-1 cells (upper panel) and the siRNA-mediated
reduction of endogenous ASC (lower panel) by immunoblot. An asterisk denotes
expression of ASC and NLS-ASC containing silent point mutations in the
sequence recognized by the siRNA preventing its degradation.
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Figure 8. A model for inflammasome formation and activation.
Cross talk between the TLR and NLR system has been proposed, where initial DAMP
recognition by TLRs triggers transcriptional up-regulation of pro-IL-1β and other
inflammasome components. Subsequently, DAMP recognition by NLRs is required for
maturation of pro-IL-1β and pro-IL-18. Our data indicate that DAMP recognition also
causes redistribution of ASC from the nucleus to the cytosol by a yet elusive
mechanism, which then can be recruited to activated NLRs to assemble
inflammasomes. The perinuclear aggregates in activated macrophages contain the core
inflammasome proteins and might represent inflammasomes.
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Study 2:
Mycoplasma: A novel activator of the inflammasome
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ABSTRACT
Mycoplasma species are very unique parasitic bacteria, which lack a cell wall.
They are the smallest known free-living organisms and are known to cause a large
number of organ-specific diseases such as pneumonia and pericarditis. Also, they
have been linked to a number of chronic inflammatory diseases. However, in spite of
the large number of pathogenic Mycoplasma species, very little is known about how the
host immune system detects and responds to infection by these organisms. IL-1beta is
a key pro-inflammatory cytokine in the innate immune defense against pathogens.
Because of its wide-ranging impacts, the release of IL-1beta is highly regulated,
involving a two-step process of transcriptional upregulation of the precursor followed by
inflammasome-mediated activation of caspase-1, which processes the precursor into
its mature form. In this study, we show that infection with Mycoplasma sp. or treatment
with the synthesized Mycoplasma-derived lipoprotein FSL1 elicits the secretion of IL1beta from monocytes and macrophages at levels, which are comparable to those
seen upon infection with known inflammasome activators. Additionally, we provide
evidence that Mycoplasma infection stimulates the nuclear to cytosolic redistribution of
the inflammasome adaptor protein ASC, an event, which our previous work has shown
to be necessary for inflammasome formation. Furthermore, we demonstrate that the
IL-1beta released by these cells is the mature, processed form, and that Mycoplasmainduced secretion of IL-1beta is dependent upon the expression of the key
inflammasome adaptor protein ASC.
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INTRODUCTION
Inflammation in response to exogenous and endogenous danger signals is
a complex and highly regulated process. Cytokines are soluble mediators that
play an indispensable role in the direction and facilitation of the immune system
in response to a wide array of pathogenic invaders. Interleukin-1beta (IL-1beta)
is a crucial inflammatory cytokine, which functions in the recruitment of white
blood cells to the site of invasion, activation of other pro-inflammatory cytokines,
and as a potent fever inducer (Dinarello, 1996). Cellular production of mature IL1beta is a complex process that involves regulation at multiple steps along the
way. IL-1beta is initially produced by the cell as an inactive 33kDa precursor,
which requires cleavage by active caspase-1 in order to become the fully active
17.5 kDa cytokine released by the cell (Thornberry, 1992). Furthermore,
caspase-1 itself must also be activated in order to exhibit proteolytic activity and
recent evidence has demonstrated that this is achieved through the assembly of
a multi-protein activation platform (Martinon, 2002). These complexes, which
have been termed inflammasomes, form in response to a large number of
diverse pathogenic associated molecular patterns (PAMPs) as well as
endogenous danger associated molecular patterns (DAMPs). Assembly of
inflammasome complexes enables activation of cytosolic pattern recognition
Nod-like receptors (NLRs) by PAMPs and DAMPs to trigger downstream
caspase-1 activation (Franchi L, 2009,Martinon F, 2007,Tschopp, 2003). Thus,
essential inflammasome components include NLRs, pro-caspase-1, and a small
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adaptor protein called apoptosis associated speck-like protein containing a
CARD domain (ASC). This small adaptor protein consists of an N-terminal Pyrin
domain (PYD), and a C-terminal caspase recruitment domain (CARD), which
both function to bridge the activation of NLRs to the generation of active
caspase-1 (Srinivasula, 2002,Stehlik, 2003,Taniguchi S, 2007,Yamamoto,
2004,Yu, 2006). Inflammasome assembly occurs when a cytosolic NLR protein
recognizes a specific pathogenic molecular pattern or endogenous danger signal,
which results in the oligomerization of the receptor in an ATP-dependent manner
(Duncan JA, 2007,Faustin B, 2007). Furthermore, activation of NLRs enables
them to recruit the adaptor protein ASC via homotypic interaction between the
PYRIN domains of each protein (Stehlik, 2007). ASC subsequently recruits procaspase-1 via a homotypic CARD-CARD interaction resulting in activation of
caspase-1 by the induced proximity mechanism (Srinivasula, 2002,Stehlik,
2003,Yu HB, 2008).
To date, a number of pathogenic as well as endogenous inflammasome
activators have been identified. The NALP3 inflammasome is the currently the
best characterized, and has been found to be required for IL-1beta release in
response to both pathogenic and endogenous molecular patterns, including
bacterial RNA (Kanneganti, 2006), double-stranded viral RNA (Kanneganti TD,
2006) the peptidoglycan component muramyl dipeptide (Kanneganti TD,
2006,Marina-García N, 2008,Martinon, 2004,Pan Q, 2007), uric acid crystals
(Martinon, 2006), and extracellular ATP (Mariathasan, 2006). Additionally,
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ligands have also been identified for, Nod1 and Nod2, which respond to and ieDAP and MDP, respectively ((Chamaillard, 2003,Girardin, 2003a,Girardin,
2003b).
Mycoplasma species are unusual pathogens that are poorly characterized.
They are the smallest known free-living organisms, which are distinguished from
other bacteria by their lack of cell wall. This unique feature of mycoplasmas
makes them difficult to culture, and as a result infections with these organisms
often go undiagnosed. Furthermore, their lack of cell wall also renders them
resistant to many commonly used antimicrobials, which in addition to acquired
resistance, makes diseases caused by these organisms difficult to treat (Bébéar
CM, 2005). Although Mycoplasma species have been associated with a large
number of organ-specific human diseases including pneumonia, pericarditis,
meningitis, and pelvic inflammatory disease, very little is known about their
interaction with the host defense system (Baseman JB, 1997,Sacht G,
1998,Waites KB, 2004). Furthermore, these organisms have also been
implicated in the pathogenesis of chronic inflammatory diseases such as
rheumatoid arthritis, asthma, and Crohn’s disease (Sacht G, 1998). Since IL1beta is a key component of the innate immune response to pathogens, and
dysregulation of its release is strongly associated with a number of
autoinflammatory disorders, we investigated whether it played a role in the host
response to Mycoplasma invasion.
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In this study, we identify Mycoplasma as a novel activator of the
inflammasome. We demonstrate that induction of human monocytic cells with
both live and heat-killed Mycoplasma species as well as the synthesized
lipoprotein FSL1 elicits the secretion of fully mature IL-1beta in an ASCdependent manner. In addition, we show that incubation of THP-1 macrophages
results in the nuclear to cytoplasmic redistribution of ASC, as well as the
formation of perinuclear aggregates. Our results provide evidence for
Mycoplasma-mediated activation of the inflammasome, and indicate that IL-1beta
release is a key component in the host defense against these pathogens.
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EXPERIMENTAL PROCEDURES
Cell culture.
THP-1 and U-937 cells were obtained from the American Type Culture Collection and
maintained as recommended by ATCC. THP-1 cells were used at low passage
numbers and were regularly tested for mycoplasma infection (MycoAlert, Lonza).
Culture supernatants were assayed and a ratio >1 between readings with reagent 1
and reagent 2 indicates the presence of mycoplasma. Generation of stable THP-1 shASC knock-down cells has been previously described (Bryan NB, 2009).
Differentiation of THP-1 cells into macrophages was achieved by seeding the cells onto
glass cover slips coated with collagen I (5µg/cm2 and incubating them overnight in
culture medium supplemented with 15 ng/ml of phorbol 12-myristate 13-acetate (PMA)
followed by further culture for 2 days. Where indicated, cells were treated with
100ng/mL of synthesized FSL1, 2x105 cfu/ml of heat killed Acholeplasma laidlawii
(HKAL), Legionella pneumophila (HKLP), and Staphylococcus aureus (HKSA)
(InvivoGen).

Isolation of primary monocytes from human peripheral blood.
Human monocytes were isolated by Ficoll-Hypaque centrifugation (Sigma) from
heparanized blood. Mononuclear cells were removed, washed in Hank’s Buffered Salt
Solution (HBSS), resuspended in serum-free DMEM and isolated by adherence to
plastic dishes. Adherent monocytes were washed and incubated in complete RPMI.
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Immunofluorescence.
1x106 THP-1 or U-937 cells were fixed in 3.7% paraformaldehyde / PBS for 30 minutes
at room temperature. Next, cells were washed twice with PBS, and incubated with
50mM glycine/PBS for 5 minutes. They were then blocked and permeabilized in 1%
BSA / 1.5% goat serum / 0.5% saponin / PBS for 30 minutes. Following blocking, the
cells were incubated with a primary polyclonal anti-ASC antibody from Chemicon
(1:200) directed against the CARD domain, or a custom-raised affinity purified
polyclonal antibody, which recognizes the linker domain (CS3 1:1000). After washing
in 0.5% saponin / PBS, cells were incubated with an AlexaFluor 488 anti-rabbit
secondary antibody in addition to phalloidin 546, which stains actin, and ToPro-3,
which stains DNA, in the blocking solution. Finally, cells were washed in PBS
containing 0.5% saponin, followed by PBS alone, and mounted with Fluoromount.
Suspension cells were stained as described above, and then adhered to poly-L-lysine
coated slides using cytocentrifugation. Images were acquired by laser scanning
confocal microscopy using a ZEIS LSM 510 microscope under a 100x oil immersion
objective.

Subcellular fractionation.
106 cells were resuspended in nuclear extraction buffer (10 mM HEPES pH 8.0, 0.5%
NP40, 1.5mM MgCl2, 10 mM KCl, 0.5 mM DTT, and 200 mM sucrose, supplemented
with protease and phosphatase inhibitors). After a 5 minute incubation on ice, nuclei
were pelleted by centrifugation at 14,000 rpm for 15 seconds, and the cytosolic
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supernatant was transferred to a new tube. Nuclei were washed once with 1 ml of
extraction buffer, and lysed in RIPA buffer (1% NP40, 1% deoxycholic acid, 0.1% SDS,
0.15 M NaCl, 0.1 M sodium phosphate pH 7.4, 2 9mM EDTA supplemented with
protease and phosphatase inhibitors). Salt and detergent concentrations of the
cytosolic fraction were adjusted to RIPA buffer concentrations and all fractions were
fully solubilized by brief sonication. 50 µg of protein lysates were separated by SDSPAGE, transferred to a PVDF membrane, and probed with a monoclonal anti-ASC
antibody at a 1:1000 dilution (MBL), an HRP-conjugated secondary antibodies at a
1:5000 dilution (Amersham Pharmacia) in conjunction with an ECL detection system
(Pierce). Membranes were stripped and re-probed with anti-GAPDH at a 1:1000
dilution (Sigma) and anti-Lamin A at a 1:500 dilution (Santa Cruz Biotechnology)
antibodies as controls for cytosolic and nuclear fractions, respectively.

Measurement of secreted IL-1beta .
IL-1beta secretion was quantified in culture supernatants using a commercial ELISA
(BD
Biosciences). Samples were analyzed in triplicate and each experiment was repeated
a minimum of three times. Briefly, THP-1 cells were incubated with HKAL, HKLP, or
HKSA in 12-well dishes for 16 hours. Following treatment, the supernatants were
centrifuged at 13,000 rpm for 15 minutes in order to remove any residual cells. The
cleared supernatants were then either stored at -80oC or immediately analyzed by
ELISA.
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Analysis of IL-1beta processing
Processing of IL-1beta was evaluated in uninduced THP-1 cells and in THP-1 cells
incubated with HKAL. Cells were seeded in a 6-well plate and cultured for 24 hours in
the presence or absence of HKAL. Following the stimulation, supernatants were
removed, and centrifuged at 13,000 rpm for 15 minutes in order to remove any residual
cells. The supernatant was then transferred to a fresh tube, and concentrated using a
Nanosep centrifugal device containing a 3K omega membrane (Sigma). Upon removal
of the supernatants, the cells were lysed in RIPA buffer (see above) and assayed for
protein concentration using BCA protein quantification kit (Pierce). 75µg of the protein
lysates, and the concentrated supernatants were supplemented with Laemli’s loading
buffer, and analyzed by SDS-PAGE on a 12% acrylamide gel. The proteins were then
transferred to a PVDF membrane, and probed with an anti-IL-1beta antibody (1:1000)
(Millipore), which recognizes both the unprocessed 33kDa form and the processed
17kDa form followed by HRP-conjugated secondary antibody. The proteins were
subsequently detected using an ECL system (Pierce).
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RESULTS

Mycoplasma species stimulate the release of mature IL-1beta from human
monocytes.
Secretion of mature IL-1beta is a two-step process that involves transcriptional
upregulation of the precursor form by NF-kB, which is subsequently processed upon
inflammasome-mediated caspase-1 activation. Therefore, we first determined if
heat-killed Acholeplasma laidlawii (HKAL) were capable of stimulating the release of
IL-1beta from human monocytes. Culture supernatants from primary monocytes
(Fig. 1A) as well as from the human monocytic THP-1 cell line (Fig. 1B) were
analyzed by ELISA following incubation with HKAL. For both primary human
monocytes and THP-1 cells, IL-1beta secretion was greatly enhanced in cells
incubated with HKAL over the untreated control cells. In addition, the amount of IL1beta released by THP-1 cells in response to HKAL treatment was comparable to
the amount elicited by the known inflammasome activators Legionella pneumophilia
(HKLP) and Staphylococcus aureus (HKSA). In order to confirm that the IL-1beta
secreted in response to HKAL was the mature 17.5 kD form, we concentrated the
culture supernatant of THP-1 cells following incubation with HKAL and analyzed it by
western blot for IL-1beta. While both the 33 kD precursor, and the mature 17kD
form were observed in cell lysates, only the processed form was detected in the
supernatant treated cells (Fig 1C). Furthermore, while untreated control cells
displayed very low levels of the IL-1beta precursor in the cell lysate, it was not
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observed in the supernatant, and the active form was not detected at all. Next, we
evaluated whether infection with live Mycoplasma sp. could stimulate the release of
IL-1beta from human monocytes. Culture supernatants fromTHP-1 cells were
analyzed as for the presence of secreted IL-1beta as above following infection with
live Mycoplasma (Fig. 1D). We found that live infection with Mycoplasma species
did result in an elevation in the release of IL-1beta over uninfected control cells.
Active, live infection was confirmed using the MycoAlert assay system (Fig. 1E).

Mycoplasma infection induces the nuclear to cytoplasmic redistribution of the
inflammasome adaptor ASC.
The release of mature 17kDa IL-1beta requires the activation of caspase-1
through inflammasome assembly. Therefore, we investigated the role of the central
inflammasome adaptor, ASC, in Mycoplasma-induced IL-1beta release. Our recent
work demonstrated that inflammasome activation and subsequent IL-1beta secretion
requires the translocation of ASC from the nucleus to the cytoplasm (Bryan NB,
2009). Therefore, we used immunofluorescence to evaluate the subcellular
localization of endogenous ASC in the human monocytic THP-1 and U-937 cell lines
following infection with Mycoplasma. In agreement with our previous report, ASC
was localized almost exclusively in the nucleus in resting monocytes (Fig. 2A).
However, live Mycoplasma infection resulted in a completely cytosolic distribution of
ASC (Fig. 2B).
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Stimulation of THP-1macrophages with HKAL induces the formation of
cytosolic ASC aggregates.
Our previous study revealed that in differentiated macrophages, ASC not only
relocalized to the cytoplasm, but it also formed perinuclear aggregates reminiscent
of those characterized in overexpression studies. Thus, we next evaluated how
stimulation with HKAL impacted ASC localization in THP-1 macrophages. Similar to
the known inflammasome activators HKSA and HKLP, HKAL also induced the
formation of perinuclear ASC aggregates in THP-1 macrophages (Fig 3A). To
confirm our immunofluorescence results, we fractionated proteins from resting or
Mycoplasma-infected THP-1 and U-937 cells into nuclear and cytosolic components,
and used immunoblotting to determine where ASC was localized. Fractionation
efficiency was confirmed by stripping and re-probing for cytosolic GAPDH and
nuclear Lamin A proteins. While a substantial portion of ASC was found in the
nuclear fraction of resting THP-1 and U-937 cells, active Mycoplasma infection
resulted in the exclusive cytoplasmic localization of ASC (Fig. 3B). Based upon
these results, and those in Figure 2, we conclude that Mycoplasma induces nuclear
to cytosolic redistribution as well as perinuclear aggregate formation of endogenous
ASC.

ASC is required for Mycoplasma-induced IL-1beta release.
In order to firmly link inflammasome activation as an essential component of
Mycoplasma-mediated IL-1beta release, we generated THP-1 cells, which stably
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expressed plasmids encoding shRNA for either the inflammasome adaptor ASC, or
firefly luciferase as a control. Using these cells, we examined whether ASC
expression was necessary for the release of IL-1beta in response to activation with
HKAL. Culture supernatants from sh-ASC or sh-control THP-1 cells were analyzed
by ELISA for secreted IL-1beta under resting conditions or following induction with
HKAL, HKLP, or HKSA. While a large induction in IL-1beta secretion was observed
in response to incubation of HKAL, HKLP, or HKSA with the control cells, loss of
ASC resulted in a significant inhibition of IL-1beta release following activation with all
three pathogens (Fig. 4). Thus, the inflammasome adaptor ASC is essential for the
secretion of IL-1beta in response to stimulation with HKAL.

The mycoplasma lipoprotein FSL1 is sufficient to cause macrophage
inflammasome activation.
Inflammasome activation occurs upon recognition of specific pathogen
associated molecular patterns (PAMPs) by cytoplasmic NLRs, which function as
pattern recognition receptors. Therefore, we next identified a specific which
Mycoplasma-derived PAMP, which could induce IL-1beta processing. Using the
THP-1 cells stably transfected with shRNA, we examined the ability of the
purified Mycoplasma lipoprotein FSL1 to induce IL-1beta maturation and release.
Treatment with synthesized FSL1 (Invivogen) stimulated the release of IL-1beta
as efficiently as heat-killed A. laidlawii in an ASC-dependent manner (Fig. 5a).
Furthermore, we once again that the released IL-1beta was indeed the
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processed, mature form by analyzing cell lysates and supernatants from
activated cells by immunoblotting (Fig. 5b). These data suggest that FSL1 is
capable of activating the inflammasome and thus is one of the NLR-recognized
mycoplasma-derived PAMPs.
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DISCUSSION
In spite of their involvement in a large number of human diseases, the
interaction between these organisms and the host immune system has not been
fully characterized. Mycoplasma sp. are completely reliant upon host cells for
nutrition, and therefore do not induce cell death. As a result, the presence of
these organisms frequently goes undetected. One mechanism by which they do
initiate an immune response is through the stimulation of macrophages via
lipoproteins containing a diacylated cysteine residue. The macrophage response
is mediated by TLR2/TLR6 heterodimers, which induce the downstream
activation of NF-kB through the adaptor MyD88 (Garcia J, 1998,Nishiguchi M,
2001,Okusawa T, 2004,Sacht G, 1998,Takeuchi O, 2000). In this study, we
examined the innate immune response to infection with Mycoplasma sp., and
provide evidence that they are capable of activating the inflammasome, and
eliciting release of mature IL-1beta.
We determined that incubation of both primary macrophages as well as THP1 cells with heat-killed A. laidlawii, induced the secretion of IL-1beta (Fig. 1a and
b). Furthermore, the amount of IL-1beta release elicited by incubation with A.
laidlawii was comparable to the amount released in response to the known
inflammasome activators HKSA (NLRP3), and HKLP (NLRP3 and NLRC4) (Case
CL, 2009,Mariathasan, 2006,Vinzing M, 2008). Additionally, live infection of
THP-1 monocytes with Mycoplasma sp. also resulted in elevated release of IL1beta (Fig. 1d and e).
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Generation of mature IL-1beta is widely believed to be a two-step process
that involves the initial transcriptional upregulation of the precursor by NF-kB
followed by inflammasome assembly and caspase-1 activation. NF-kB activation
in monocytic cells is usually achieved through stimulation of Toll-like receptors
(TLRs), while inflammasome assembly requires the activation of cytoplasmic
NLRs ((Becker CE, 2007,Mariathasan, 2007). Mycoplasma sp. have previously
been shown to interact with TLR2/TLR6 and thereby initiate downstream
activation of NF-kB, which regulates the transcription of pro-IL-1beta. Therefore,
we confirmed that the Il-1beta secreted from cells was the fully active, mature
form, which is produced as a result of caspase-1 activation by analyzing the
concentrated supernatant as well as the cell lysates by immunoblotting. The vast
majority of IL-1beta present in the cell lysate and all of the IL-1beta present in the
supernatant of Mycoplasma-activated cells was the mature 17.5 kD form (Fig.
1c). This data demonstrates that the IL-1beta detected by ELISA is indeed the
processed, mature form. Furthermore, the presence of the mature 17.5 kD form
of IL-1beta in the cell lysate indicates that it is being processed by caspase-1
prior to its release from the cell, and not by extracellular proteases.
Next, we evaluated how Mycoplasma infection impacted the subcellular
distribution of the inflammasome adaptor protein ASC. ASC is a crucial mediator
of inflammasome assembly initiated by the activation of multiple NLRs following
recognition of their respective PAMPs or DAMPs. We recently demonstrated that
in resting monocytes and macrophages, ASC is localized to the nucleus.
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However, upon stimulation with previously identified inflammasome ligands, ASC
is rapidly redistributed to the cytoplasm, where it subsequently forms large
perinuclear aggregates that incorporate the key components of the
inflammasome. Furthermore, we showed that nuclear export of ASC is essential
to inflammasome assembly and IL-1beta maturation (Bryan NB, 2009). Live
infection of both THP-1 and U-937 monocytes with Mycoplasma sp. resulted in
the complete cytoplasmic redistribution of ASC, while the uninfected cells
retained it inside the nucleus. (Fig. 2a and b and 3b).
We then examined whether stimulation of THP-1 macrophages with
Mycoplasma could induce the formation of perinuclear ASC aggregates. Just as
observed with the known inflammasome activators HKLP and HKSA, incubation
of THP-1 macrophages with HKAL induced the formation of ASC aggregates.
This finding provides further evidence that Mycoplasma sp. induce
inflammasome assembly based upon our previous work demonstrating that ASC
co-localizes with other key inflammasome proteins including caspase-1 and
NLRP3 receptor in these structures (Bryan NB, 2009).
Next, we established that ASC is required for IL-1beta release in response to
activation with HKAL. To achieve this, we employed THP-1 cells with a stable
knock-down of endogenous ASC (Fig. 4b). These cells exhibited a greatly
diminished capacity to secrete IL-1beta following induction with HKAL, HKSA, or
HKLP in comparison to the control cells (Fig. 4). Therefore, release of IL-1beta
in response to HKAL is dependent upon ASC.
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Finally, we identified the lipoprotein FSL1 as an inflammasome-activating
PAMP. We demonstrated that treatment of THP-1 cells with purified FSL1
elicited the secretion of mature IL-1beta in an ASC-dependent manner.
Furthermore, the levels of IL-1beta released were comparable to those observed
following induction with HKAL.
In summary, we demonstrated that infection with Mycoplasma sp. causes the
nuclear to cytoplasmic redistribution of the inflammasome adaptor protein ASC
and elicits the secretion of mature IL-1beta in an ASC-dependent manner. Our
data identify Mycoplasma sp. as a novel activator of the inflammasome with the
lipoprotein FLS1 acting as one of the NLR-activating PAMPs, providing further
insight into the host defense mechanisms employed against this pathogen.
Additionally, our results also suggest the possibility that chronic inflammasome
activation and subsequent IL-1beta release may be the mechanism by which
latent Mycoplasma infection can lead to the development of chronic inflammatory
disorders such as asthma and rheumatoid arthritis. While the specific NLR
receptors necessary for the recognition of Mycoplasma sp. remain elusive, the
requirement for ASC indicates that one or more of the fourteen receptors, which
contain a PYD are involved. Studies aimed at identifying the receptors involved
in the response to Mycoplasma sp. are currently underway.
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Figure 1. Mycoplasma sp. Induce secretion of mature IL-1beta from THP-1
monocytes.
(A). Culture supernatants from primary human macrophages under resting
conditions or stimulated with heat-killed Acholeplasma laidlawii (HKAL) were
collected and analyzed for secretion of IL-1beta by ELISA. Results are
presented as a fold - increase in secretion over the untreated control.
(B). Culture supernatants from THP-1 monocytes under resting conditions, or
following treatment with HKAL (2x105), Gram-negative HKLP (2x105 cfu), or
Gram-positiveHKSA (2x105 cfu) were collected and analyzed for the presence of
secreted IL-1beta. Results represent three independent experiments +/- SD. and
are presented as pg/mL of released IL-1beta.
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(C). THP-1 cells were either left untreated or stimulated with HKAL. The culture
supernatants and cell lysates were collected separately, and analyzed by
immunoblot for the expression of processed and unprocessed IL-1beta.
(D). Culture supernatants were collected from THP-1 cells under resting
conditions or following incubation with a live Mycoplasma sp. and analyzed for
released IL-1beta by ELISA. Results represent an average of three independent
experiments +/- SD, and are presented as pg/mL of secreted IL-1beta. The
infection status of the cells was confirmed by evaluation of culture supernatants
using a commercial kit (E).
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Figure 2. Live infection with Mycoplasma sp. induces nuclear to cytosolic
redistribution of ASC in human monocytic cell lines.
Subcellular localization of endogenous ASC was evaluated in two human
monocytic cell lines, THP-1 and U-937 under resting (A), and upon live infection
with Mycoplasma sp. (B).
Cells were fixed and immunostained with a
monoclonal antibody against ASC (MBL).
An AlexaFluor-488-conjugated
secondary antibody was used in conjunction with ToPro-3 to counterstain the
nuclear DNA, and AlexaFluor 546-conjugated phalloidin to visualize the actin
cytoskeleton. Images were obtained using laser scanning confocal microscopy
and the panels from left to right represent ASC (green), nucleus (blue), actin
(red), and a merged compilation.
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Figure 3. Stimulation of THP-1 macrophages with HKAL results in
formation of perinuclear ASC aggregates.
(A). Subcellular localization of endogenous ASC was evaluated in PMAdifferentiated THP-1 macrophages following activation with HKAL, Gram-positive
HKSA, and Gram-negative HKLP. Cells were fixed following 6 hours of
incubation and immunostained with a custom-raised polyclonal anti-ASC
antibody (CS3). An anti-rabbit AlexaFluor-488 conjugated secondary antibody
was used in addition to ToPro-3 to counterstain the nuclear DNA, and
AlexaFluor-546 conjugated phalloidin in order to visualize the actin cytoskeleton.
Images were acquired using laser scanning confocal microscopy (Zeiss LSM
510)and the panels from left to right demonstrate the distribution of ASC (green),
nuclei (blue), the actin cytoskeleton (red) and a merged compilation.
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(B). Localization of ASC was analyzed by subcellular fractionation of THP-1 and
U-937 monocytes under resting conditions and following incubation with live
Mycoplasma sp. 1x106 cells were fractionated by differential centrifugation into
nuclear and cytoplasmic fractions, and normalized for protein contents. 50ug of
protein lysate was analyzed by immunoblotting with a monoclonal anti-ASC
antibody, followed by an anti-mouse HRP-conjugated secondary antibody.
Fractionation efficiency was confirmed by stripping the membrane, and reprobing for cytosolic GAPDH and nuclear Lamin A proteins.
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Figure 4. ASC is required for IL-1beta secretion induced by HKAL.
(A). THP-1 cells were stably transfected with either control shRNA (black bars)
or shRNA targeting ASC (gray bars). 1x106 cells were seeded in triplicate into a
12-well dish and were either left untreated or were stimulated with HKAL (1x105
cfu), HKLP (1x105 cfu), or HKSA (1x105 cfu). Supernatants were then collected
and analyzed for secreted IL-1beta by ELISA. Results represent an average of
three independent experiments +/- SD and are presented as pg/mL of secreted
IL-1beta.
(B). Efficient knock-down of ASC was confirmed in stably transfected THP-1
cells by immunoblot. 1x106 cells stably expressing control shRNA and ASC
shRNA were directly lysed in Laemli buffer and separated by SDS-PAGE. The
proteins were then transferred to PVDF membrane, which was probed with a
custom-raised polyclonal anti-ASC antibody (CS3) followed by an anti-rabbit
HRP-conjugated secondary antibody. To ensure equal loading, the blot was
subsequently stripped and re-probed with a monoclonal anti-GAPDH antibody.
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Figure 5. The mycoplasma lipoprotein FSL1 is sufficient to cause
macrophage inflammasome activation.
THP-1 cells and THP-1 cells with ASC knock-down were left untreated, treated
with HKAL (2x105 cfu/ml), or purified FSL1 (100 ng/ml), followed by analysis of
culture supernatants for released IL-1β by ELISA (A) and upon concentration of
the culture supernatant from THP-1 cells also by immunoblot in culture
supernatants (SN) and whole cell lysates (WCL) (B).
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Study 3:
Identification and Characterization of Three Novel ASC Isoforms
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ABSTRACT
Generation of mature IL-1beta requires the activation of caspase-1, which
occurs in multi-protein complexes termed inflammasomes. Apoptosis associated
speck-like protein containing a caspase-recruitment domain (ASC), functions as
a crucial adaptor protein in inflammasome assembly, and gene ablation studies
have consistently demonstrated it is necessary for caspase-1 activation in
response to a large number of pathogenic stimuli as well as endogenous danger
signals. Structurally, ASC consists of two protein interaction domains; an Nterminal PYD, which is necessary for interaction with upstream cytosolic NLR
receptors, and a C-terminal CARD domain, which is required for it interaction
with caspase-1. Here, we identify three novel ASC isoforms. ASCb retains both
an in tact PYD and CARD domains, but is lacking the linker region, which joins
them. In contrast, ASCc possesses a large in-frame deletion in the PYD, and
ASCd consists of only the first thirty-five amino acid residues of the PYD, fused
to a novel peptide sequence. We characterize these isoforms with regards to
their subcellular distribution, their ability to interact with NLRP3 and caspase-1,
and evaluate their capacity to function as an inflammasome adaptor protein.
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INTRODUCTION
Apoptosis associated speck-like protein containing a caspase recruitment
domain (ASC) is a small adaptor protein, which functions in both apoptotic
(McConnell, 2000,McConnell, 2004,Ohtsuka, 2004,Parsons MJ, 2006) and
inflammatory pathways. Structurally, ASC consists of an N-terminal PYRIN
domain and a C-terminal caspase recruitment domain (CARD), which are both
members of the death domain fold super family and function as protein
interaction motifs. Both of these domains are required for ASC oligomerization
and the formation of the characteristic perinuclear aggregates, which occur upon
ectopic expression of ASC (Masumoto, 2001).
In innate immunity, ASC functions as an essential adaptor protein in the
activation of caspase-1, which is essential for the maturation of the proinflammatory cytokines IL-1beta and IL-18 (Mariathasan, 2004,Srinivasula,
2002,Stehlik, 2003b,Yamamoto, 2004). In addition, it can also function as a
modulator of NF-kB activity (Sarkar, 2006,Stehlik, 2002). Caspase-1 is activated
upon the assembly of multi-protein complexes termed inflammasomes, which
form in response to pathogenic as well as endogenous danger signals (Martinon,
2002). Caspase-1 activation results in the subsequent processing of the proinflammatory cytokines IL-1beta and IL-18 from their inactive precursor forms to
their active, secreted forms (Martinon F, 2007,Yu HB, 2008). Through protein
interactions mediated by both its PYD and CARD domains, ASC serves as an
essential link between pathogen recognition and caspase-1 activation (Taniguchi
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S, 2007). Inflammasome assembly and activation is initiated when cytosolic
Nod-like receptors (NLRs), which function as pattern recognition receptors, are
activated in response to specific pathogen associated molecular patterns
(PAMPs) such as bacterial RNA (Kanneganti, 2006), or endogenous danger
associated molecular patterns, such as extracellular ATP (Mariathasan, 2006).
Activation of these receptors results in an ATP-dependent oligomerization and
the recruitment of ASC via homotypic PYD-PYD interaction (Duncan JA,
2007,Faustin B, 2007). Subsequently, ASC uses its CARD to recruit caspase-1
molecules to the complex, which can then be activated by an induced proximity
mechanism.
Post-transcriptional modifications, such as alternative splicing are a
common occurrence in eukaryotic cells, and as much as 94% of all human genes
undergo alternative splicing (Wang ET, 2008). They allow for enhanced protein
diversity without requiring additional genes. Alternative RNA splicing is a
particularly common occurrence in genes, which regulate apoptotic and
inflammatory pathways (Leeman JR, 2008,Schwerk C, 2005). It enables cells to
generate multiple proteins from a single mRNA transcript. For example, shorter
isoforms of the proteins Rip2 and Nod2 have been identified (Krieg A,
2009,Rosenstiel P, 2006). Both of these proteins have been found to participate
in the activation of the transcription factor NF-kB as well as caspase-1.
Furthermore, in the case of Nod2, the shorter isoform was found to function as
an antagonist for both Nod2-mediated NF-kB actiation and IL-1beta maturation.
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In this study, we report the identification and characterization of three
novel structural isoforms of ASC, which we designated ASCb, ASCc, and ASCd.
The structural modifications of the three additional isoforms are varied and
include a deletion of the central linker domain, an in-frame deletion of a large
portion of the PYD, and a truncated PYD followed by the replacement of the
remainder of the protein with a new peptide. These structural alterations resulted
in very different subcellular localization patterns, which were distinct from each
other as well as from full-length ASCa. In addition, the ability to interact with the
known binding partners NALP3 and pro-caspase-1 was impacted as a result of
structural changes observed with ASCc and ASCd, but not ASCb. Furthermore,
while ASCb still retains still retains some ability to serve as an adaptor in the
caspase-1-activating inflammasome, ASCc and ASCd are completely unable to
function in this capacity, but may be involved in “fine-tuning” inflammasome
responses.
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EXPERIMENTAL PROCEDURES

Cell Culture.
HEK 293 cells were obtained from the American Type Culture Collection and
maintained in a humidified incubator at 37oC with 5% CO2. They were
propagated in DMEM supplemented with 10% FBS, 2mM L-glutamine, 0.1mM
non-essential amino acids, 1mM sodium pyruvate, 1.5 g/L sodium bicarbonate,
and 1% penicillin/streptomycin antibiotics. HEK 293T cells were transiently
transfected using Polyfect (Qiagen) or Superfect (invitrogen) according the
procedures recommended by the manufacturer.

Expression Plasmids
A search of the publicly available expressed sequence tag (EST) database
revealed three potential ASC isoforms ASCb (accession number BM456838),
ASCc (accession number BE560228), and ASCd (accession number
BM920038). The complete open reading frame of each isoform was amplified by
PCR. ASC isoforms b and d were amplified using the primers [5’-CGGAATTC
GATCCTGGAGCCATGGG-3’(forward): 5’-CGCTCGAGTGACCGGAGTGT
TGCTG-3’ (reverse) for 40 cycles. ASCc was amplified using the primers [5’CGGAATTCGATCCTG GAGCCATGGG-3’(forward): 5’-CGCTCGAGCCGGTG
CTGGTCTATAA-3’ (reverse). They were subsequently cloned into a pcDNA3
vector (Invitrogen) possessing an N-terminal myc –epitope tag
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All other expression constructs (ASC, pro-IL-1beta, pro-caspase-1,
NALP3R260W) have been previously described (Chu, 2001,Damiano, 2001,Lee,
2001,Stehlik, 2003b).

Measurement of secreted IL-1beta from a reconstituted inflammasome
293T cells were counted and seeded into type-I collagen-coated 12-well dishes,
and allowed to adhere overnight. They were co-transfected in triplicate the
following day with expression constructs encoding the constitutively active
NALP3R260W mutant (0.675ug), pro-caspase-1 (0.15ug), and mouse pro-IL-1beta
(0.375ug), and each of the identified ASC isoforms (0.04ug ASCa and ASCb,
and 0.15ug ASCc and ASCd), either alone or in the presence of full-length ASC.
The total amount of DNA was kept constant with the addition of an empty
pcDNA3 vector as necessary. The media was replaced 24 hours posttransfection, and at 48 hours post transfection, the supernatants were collected,
centrifuged at 13,000 rpm for 15 min at 4oC, in order to remove any detached
cells. The supernatants were subsequently stored at -80oC or immediately
analyzed by ELISA for IL-1beta release according to the manufacturer’s protocol
(BD Biosciences).
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Immunofluorescence
293T cells were seeded onto Type I collagen-coated glass coverslips in 6-well
plates, and allowed to adhere overnight. The following day they were transfected
with plasmids encoding each of the ASC isoforms alone or in addition to GFPNALP3R260W, GFP-pro-caspase-1 (C/A mutant), or full-length HA-tagged ASC.
Forty-eight hours post-transfection, they were fixed in 3.7% paraformaldehyde for
30 minutes at room temperature. Following two washes in PBS and a five
minute incubation in 50mM glycine, the cells were blocked and permeabilized in
0.5% saponin/ 1.5% normal goat serum/ 1% BSA/ PBS for thirty minutes. They
were then immunostained using a polyclonal anti-myc antibody (Santa Cruz
1:200) or a monoclonal anti-myc antibody (Millipore 1:200). A polyclonal anti-HA
antibody (Santa Cruz) was also used. After washing in 0.5% saponin/PBS, cells
were incubated in blocking solution containing an AlexaFluor 488 or 546
conjugated secondary antibody directed against either mouse or rabbit (1:200).
ToPro-3 (1:200) and AlexaFluor 546 conjugated phalloidin (1:100) were used to
visualize the nucleus (DNA), and the actin cytoskeleton respectively. Images
were obtained using laser scanning confocal microscopy (Zeiss LSM 510) under
a 100x oil-immersion objective.

In vitro protein-interaction assay
All ASC isoforms were in vitro translated and biotinylated using a TNT Quick
Coupled Transcription/Translation kit (Promega) according to the manufacturer’s
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protocol. GST-caspase-1-CARD was purified from E. coli DH5-alpha cells,
following induction with 1mM IPTG for 4 hours at room temperature. Cells were
resuspended in 2mL STS buffer (10mM Tris pH 8.0, 1mM EDTA, and 150mM
NaCl) for every 100mL of culture, and lysed by several rapid freeze/thaw cycles
followed by the addition of 1mg/mL of lysozyme. After a 30 minute incubation on
ice, 10mM of DTT and 1.4% sodium sarkosyl were added, and the lysate was
carefully sonicated, and cleared by centrifugation at 13,000 rpm for 15 minutes.
The extraction procedure was repeated, supernatants were pooled, adjusted to
4% Triton X-100 was added and incubated with immobilized glutathione
sepharose overnight at 4oC. Beads were washed three times with PBS and
stored at 4oC in PBS/0.1% sodium azide.
The immobilized GST proteins were blocked for 30 minutes at room
temperature in HKMEN buffer (142.4mM KCl, 5mM MgCl2, 10mM HEPES (pH
7.4), 0.5mM EGTA, 1mM EDTA, 0.2% NP-40, 1mM DTT) supplemented with
protease inhibitors (Roche) and 1mg/mL BSA. Following one wash with HKMEN
buffer, the beads were incubated overnight on a rotator with the in vitro translated
ASC isoforms. Bound proteins were washed 4 times in HKMEN buffer
supplemented with protease inhibitors, boiled in Laemmli buffer, separated by
SDS/PAGE, transferred to a PVDF membrane and probed with a monoclonal
anti-myc antibody (Millipore) followed by an HRP-conjugated anti-mouse
secondary antibody. The blot was then developed with chemiluminescent
reagents (Millipore).
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RESULTS
Identification of three novel ASC isoforms
A search of the publicly available EST database revealed the existence of
three novel isoforms of ASC expressed in human tissues. The first isoform,
ASCb, is the most frequently expressed isoform with the exception of full-length
ASC. This isoform is distinguished from full-length ASC by an in-frame deletion
resulting in the loss of the linker domain, which corresponds to amino acid
residues 93-111 (Fig. 1). Therefore, the resulting protein retains fully intact PYD
and CARD domains. However, these domains are now directly fused together,
rather than being separated by a linker region. The second isoform we identified,
ASCc, was also generated by an in-frame deletion. In contrast to the deletion
giving rise to ASCb that leaves both protein-interaction domains intact, the
deletion in ASCc results in the loss of amino acid residues 26-85, which compose
a large portion of the PYD (Fig. 1). However, both the linker domain and the
CARD domain of this isoform remain unaffected. ASCd, retained the least
amount of the full-length ASC structure. Interestingly, ASCd is composed of only
the first thirty-five amino acid residues of ASC, which contain the first two alphahelices of the PYD. The remainder of the ASC protein has been completely
deleted and replaced by sixty-nine novel amino acids (Fig. 1).
Furthermore, two of the three isoforms, ASCb and ASCc, were likely
generated through the post-transcriptional process of alternative mRNA splicing
as both of the regions deleted in these isoforms are flanked by potential splice
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donor (SD) and splice acceptor (SA) sites. These regions closely resemble the
consensus sequences previously characterized for SD ([C/A]AGGT[A/G]AGT)
and SA ([C/T10-11]N[C/T]AG[G/A] sites.

ASC isoforms display different localization patterns from full-length ASC
and each other.
Previous studies with full-length ASC have revealed a very unique
characteristic of this protein. In addition to diffuse nuclear and cytoplasmic
subcellular distribution patterns, ectopic expression of full-length ASC results in
the formation of perinuclear aggregates, which have been termed ‘specks’.
Furthermore, our laboratory recently demonstrated that while endogenous ASC
is predominantly nuclear in resting macrophages, perinuclear aggregates of ASC
are observed upon activation with inflammatory stimuli. Therefore, we first
evaluated how the structural alterations observed with each of the ASC isoforms
impacted the subcellular localization of these proteins.
Expression plasmids encoding each of the ASC isoforms were transiently
transfected into HEK 293 cells, and their subcellular distribution was analyzed by
immunofluorescent microscopy. As shown in Figure 2 (top panel), expression of
full-length ASCa resulted in the formation of the previously characterized
perinuclear aggregate. However, none of the other isoforms retained the
capacity to form these structures. Rather, each isoform exhibited its own, unique
localization pattern. ASCb displayed a diffuse, exclusively cytoplasmic
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subcellular distribution (Figure 2, second panel). This staining pattern further
distinguishes it from ASCa, which is frequently found in the nucleus. ASCc was
also found in the cytoplasm. However, this isoform oligomerized into long,
filamentous structures rather than exhibiting a diffuse staining pattern (Fig. 2,
third panel). Unlike ASCb and ASCc, ASCd was occasionally found in the
nucleus. Furthermore, it displayed a more vesicular-type localization pattern,
which was in contrast with the diffuse localization of ASCb and the oligomerized
filaments of ASCc (Figure 2, bottom panel).

ASC isoforms exhibit differences in their ability to interact with other
inflammasome proteins, and function in IL-1beta processing.
It has become well established that in its capacity as an inflammasome
adaptor protein, ASC directly interacts with other components of this multi-protein
complex. Additionally, previous studies performed by us as well as others have
demonstrated that other inflammasome proteins, including upstream NLR
receptors and pro-caspase-1, are recruited to perinuclear aggregates when coexpressed with ASCa. Furthermore, our examination of endogenous ASC
revealed that both endogenous NLRP3 and caspase-1 are recruited into
aggregates following activation with E. coli RNA. Therefore, we next examined
whether each of the individual ASC isoforms could interact with other
inflammasome proteins. HEK 293 cells were co-transfected with the
constitutively active GFP-tagged NLRP3 R260W mutant, and each isoform and
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subsequently analyzed for co-localization by immunofluorescence (Fig. 3A). As
expected, full-length ASCa and NLRP3R260W co-localized in the previously
described perinuclear aggregates. In addition, ASCb, which still retains a fully
intact PYD, also co-localized with NLRP3R260W. Intriguingly, co-expression of
ASCb with the upstream NLRP3R260W receptor altered its diffuse cytoplasmic
localization pattern and resulted in the formation of cytoplasmic aggregates.
However, while these aggregates did exhibit a perinuclear localization, they were
not as small and condensed as those observed with ASCa. Finally, neither
ASCc nor ASCd displayed any co-localization with upstream NLRP3R260W, as
expected due to the deletion of the part of the PYD, which is necessary for this
interaction.
Next, we evaluated whether each of the ASC isoforms were capable of
interacting with pro-caspase-1 (C/A). We transiently co-transfected HEK 293
cells with GFP-pro-caspase-1 and each of the ASC isoforms. Since previous
studies have demonstrated that cells may release active caspase-1, we utilized
an enzymatically inactive C/A mutant. Following transfection, the cells were
fixed, and co-localization was analyzed by immunofluorescence. ASCa, ASCb,
and ASCc all co-localized with pro-caspase-1, while ASCd (Fig. 3B, bottom
panel) did not, as expected due to its lack of the CARD. As observed with
NLRP3, ASCa recruited caspase-1 into perinuclear aggregates (Fig. 3B, top
panel). Additionally, caspase-1 was also found to co-localize with ASCc in the
long filamentous structures formed by this isoform (Fig. 3B, third panel). ASCb,
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on the other hand, retained the diffuse, cytosolic localization pattern that it
exhibited when expressed alone. Furthermore, it only co-localized with
cytoplasmic caspase-1, as it was excluded from the nucleus (Fig. 3B, second
panel). In addition, we also examined the ability of in vitro translated ASCa and
ASCb to directly interact with the CARD domain of caspase-1. As shown in
figure 3D, both ASCa and ASCb are capable of direct binding to the GST-tagged
CARD domain of caspase-1.
Next, we wanted to determine how the different ASC isoforms impact their
ability to function as an inflammasome adaptor protein. Therefore, we
reconstituted the inflammasome in HEK 293 cells, which lack endogenous
expression of all inflammasome components, but do possess the ability to
release mature IL-1beta, once it is generated. Cells were transiently cotransfected with expression plasmids encoding pro-IL-1beta, pro-caspase-1, and
each of the ASC isoforms in the presence or absence of the constitutively active
NLRP3R260W. Culture supernatants were collected thirty-six hours posttransfection and analyzed for released IL-1beta by ELISA. As shown in figure 3,
only those ASC isoforms, which possessed intact PYD and CARD domains,
ASCa and ASCb, were capable of forming a functioning inflammasome, and
generating mature IL-1beta (Fig. 3C). Neither ASCc, nor ASCd were able to
generate mature IL-1beta, which suggests that the structural alterations observed
in these isoforms render them unable to function as an inflammasome adaptor
protein. Intriguingly, loss of the linker region resulted in a decrease in the IL142

1beta secretion, indicating that while this isoform can function as an
inflammasome adaptor, it is less efficient than full-length ASCa.

Full-length ASC a co-localizes with ASCb and ASCc
Previous studies have demonstrated that ASC is capable of selfinteraction via binding at either protein interaction domain. Furthermore, one of
the major mechanisms of inflammasome regulation involves the disruption of the
protein-protein interactions between NLRPs and ASC, or between ASC and
caspase-1 by pyrin only proteins (POPs) or CARD-only proteins (COPs)
respectively. Therefore, we wanted to explore the possibility that ASC b and
ASCc could interact with full-length ASCa, and potentially exert influence over
inflammasome assembly and function. First, we utilized immunofluorescence to
evaluate how co-expression of full-length ASCa, with either ASCb or ASCc
impacted the subcellular localization of the isoforms. Interestingly, co-expression
of ASC isoforms a and b resulted in the co-localization of these two proteins in
perinuclear aggregates. However, the aggregates differed from those, which are
observed upon overexpression of ASCa. Co-expression of ASCa and ASCb
resulted in the formation of large, irregularly shaped perinuclear aggregates,
rather than the small, circular structures formed by ASCa alone (Fig. 4, top
panel). Co-expression of ASCc with full-length ASCa also altered its subcellular
distribution. Instead of forming long filamentous structures, ASCc was recruited
to the perinuclear ASCa aggregates. However, unlike those observed upon co143

expression with ASCb, these aggregates maintained all of the previously
identified characteristics of an ASC ‘speck’ (Fig. 4, bottom panel). Intriguingly,
this is the same localization pattern observed when ASCa is co-expressed with
either a POP or a COP, suggesting that ASCc may compete with caspase-1 for
binding to the CARD domain of full-length ASCa.
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DISCUSSION
In this study, we report the identification of three novel isoforms of the
inflammasome adaptor protein ASC, designated ASCb, ASCc, and ASCd. Two
of these isoforms are most likely generated through alternative splicing of ASC
mRNA, while the mechanism, which gives rise to ASCd remains unclear. Each
isoform exhibits unique structural modifications, which have a significant impact
on their localization as well as their ability to participate in inflammasome
assembly. As a result, alternative mRNA splicing of ASC may represent a novel
regulatory mechanism for inflammasome assembly, and subsequent IL-1beta
release.
ASCb was the most commonly expressed novel isoform yielded by our
search of the EST database.

It was second only to full-length ASCa in its

frequency of expression, suggesting that it is widely expressed in human tissues.
While much work has been devoted to elucidating the structure and function of
the

two

protein-interacting

domains

of

ASC

(Masumoto,

2001,Moriya,

2005,Stehlik, 2002,Stehlik, 2003b), no studies have been undertaken, which
evaluate the role of the linker domain in the functional or localization properties of
ASC. Discovery of a novel ASC isoform, which lacks this region, enabled us to
evaluate for the first time the contribution of this domain to the characteristics of
ASC.
Previous studies with ASC have shown that enforced overexpression of
this protein results in the formation of perinuclear aggregates termed specks
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(Fig.2) (Masumoto, 1999,T Fernandes-Alnemri, 2007). In this study, we found
that deletion of the linker domain prevented the formation of these structures.
Rather, ASCb displayed a diffuse, cytosolic localization pattern. These results
demonstrate that the linker domain is necessary for the spontaneous formation of
perinuclear aggregates upon individual overexpression of ASC. However, coexpression with constitutively active NLRP3R260W (Fig. 3) or full-length ASCa, but
not caspase-1 (Fig. 4), was able to restore aggregate formation, although these
aggregates were larger and more irregular in shape than those observed with
full-length ASCa. This data suggests that engagement of the PYD of ASCb with
upstream NLRPs or ASCa can induce the aggregation of ASCb. These results
are consistent with previous studies, which have suggested that the PYD of ASC
functions as the oligomerization domain, while the ASC CARD is the effector
domain (Srinivasula, 2002).
Functionally, ASCb was the only novel ASC isoform, which exhibited the
ability to serve as an adaptor protein in a reconstituted inflammasome, as
measured by IL-1beta release. However, lack of a linker domain did render
ASCb less efficient in this capacity, than the full-length ASCa (Fig. 3c). One
possible explanation for these results is that the linker domain of ASC confers
flexibility to the protein, which is necessary in order to efficiently aggregate with
NLRP3 and caspase-1. This hypothesis is supported by our
immunofluorescence data, which showed that co-expression of ASCa and ASCb
not only resulted in aggregation of the previously diffuse ASCb, but also resulted
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in disruption in the architecture of the full-length ASC aggregate. There is also
less efficient recruitment of caspase-1 into ASC-containing aggregates, and thus
dampened inflammasome activity and IL-1beta maturation.
ASCc exhibited functional and localization properties, which differed from
both ASCa and ASCb. Overexpression of ASCc resulted in the formation of long
cytoplasmic filaments. The formation of these structures was not unexpected, as
the ASCc protein possesses a severely truncated PYD, while leaving the linker
and CARD domains intact. Thus, this isoform is essentially comprised of an
individual CARD domain, a member of the death domain fold superfamily, and
previous studies have revealed that long filamentous structures are the result of
ectopic expression of individual members of this family (Masumoto, 2001,Siegel,
1998). Also as predicted, this isoform retained the ability to co-localize with
caspase-1, which was also recruited into the filaments, while co-localization with
NALP3R260W was not observed. These results are consistent with previous work
demonstrating that the interaction between ASC and caspase-1 is mediated by
the CARD (Srinivasula, 2002,Stehlik, 2003b), while the interaction between ASC
is upstream NLRs is mediated by the PYD (Stehlik, 2007). In addition to colocalization with caspase-1, ASCc was also able to co-localize with full-length
ASCa. Furthermore, ASCc was recruited into the perinuclear aggregates,
although without disrupting their structure, as occurred with co-expression of
ASCb.
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Functionally, ASCc was completely deficient in the capacity as an
inflammasome adaptor protein. In a reconstituted inflammasome, it was
incapable of eliciting IL-1beta release above basal levels. Structurally, this
protein most closely resembles that of a CARD-only-protein (COP). This group
of proteins includes several proteins including COP, ICEBERG, Pseudo-ICE, and
INCA, and is characterized by the fact that all members are composed solely of a
CARD domain (Druilhe, 2001,Humke, 2000,Lamkanfi, 2004,Lee, 2001,Stehlik C,
2007). Like their PYD-only couterparts (POPs), these proteins function as
dominant-negative antagonists of the inflammasome. However, unlike POPs,
COPs prevent inflammasome activation via the disruption of ASC-caspase-1
interaction, rather than blocking the interaction between NLRs and ASC (Bedoya
F, 2007,Dorfleutner, 2007a,Dorfleutner, 2007b,Stehlik, 2003a). The similarities
between ASCc and COPs raised the intriguing possibility that ASCc may also
function as an inflammasome inhibitor. This hypothesis is supported by our data
showing that ASCc co-localizes with both caspase-1 and full-length ASCc,
suggesting an interaction with one or both of these proteins. Furthermore, ASCc
was recruited into the perinuclear aggregates formed by ASCa.
ASC d is the most unusual of the novel ASC isoforms we identified. It is
the smallest of the isoforms we identified and its retention of only the first thirtyfive amino acid residues of the PYD, comprising the alpha helices 1 and 2 makes
it the isoform. Like ASCb and ASCc, ASCd was predominantly cytoplasmic (Fig.
2, bottom panel). However, we did occasionally observe this isoform in the
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nucleus (data not shown). Furthermore, while it did not form an ASC ‘speck’, this
protein was frequently found to coalesce into multiple punctate structures (Figs. 2
and 3). As predicted by its lack of a CARD domain, ASCd did not co-localize
with caspase-1 (Fig. 3b). Additionally, it also did not co-localize with
NLRP3R260W, suggesting that the portion of the PYD expressed by this isoform
was insufficient to mediate an interaction with this NLR (Fig. 3a), which usually
requires residues in alpha-helices 1 and 4, or 2 and 3. This result is consistent
with recent evidence published by Srimathi et al. predicting that the interaction
between ASC and NLRP3 occurs at a positive electrostatic potential surface
patch (EPSP) on the PYD of ASC formed by Lys21, Lys22, Lys26 and Arg 41, and a
negative EPSP on NLRP3 (Srimathi T, 2008). While ASCd does possess the
three key lysine residues, it no longer contains an arginine at position 41.
Therefore, the structural alterations resulting in the loss of this key amino acid
residue likely caused a disruption of the positive EPSP and rendered this protein
incapable of interacting with NLRP3. The inability of this protein to interact with
the key inflammasome components caspase-1 and NLRP3 is further supported
by the lack of IL-1beta released upon reconstitution of the inflammasome with
ASCd, rather than full-length ASCa (Fig. 3c).
Overall, our data suggest that alternative splicing of the
inflammasome adaptor ASC resulting in multiple isoforms of this protein may
serve as a novel regulatory mechanism for “fine-tuning” inflammasome
responses. We have identified and characterized three novel isoforms with
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regards to their subcellular distribution as well as their ability to function in
inflammasome assembly. Furthermore, ASCb provided us with a tool to evaluate
the role of the linker domain in inflammasome assembly, and our data show that
it is required for maximal activation of the inflammasome. Additionally, ASCc
may represent a novel COP, which functions as an inhibitor of inflammasome
formation through the disruption of the ASCa and caspase-1 interaction. Future
studies are needed to better characterize the significance of ASC splicing in
addition to determining the specific cell types and tissues, which express these
proteins, and their possible influence on other functions of ASC, such as its role
in apoptosis.
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Figure 1. Structural alterations in the protein organization of ASC isoforms
(A) Clustal alignment of four different ASC isoforms. ASC a represents the
previously characterized full-length ASC protein consisting of an N-terminal PYD,
a central linker domain, and a C-terminal CARD domain. ASC b represents a
splice variant in which the central linker domain corresponding to amino acid
residues 93-111 has been deleted. ASC c represents a splice variant in which a
large portion of the N-terminal PYD corresponding to amino acid residues 26-85,
has been removed. ASC d represents an isoform, which possesses only the first
35 amino acid residues of the ASC PYD. The remainder of the protein has been
replaced by a novel 69 amino acid peptide.
(B). Schematic representation of the ASC isoforms demonstrating the regions of
the protein, which have been removed or altered.
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Figure 2. Subcellular distribution of ASC isoforms
Subcellular localization of each ASC isoform was examined in HEK 293T cells,
which were transiently transfected with plasmids encoding individual ASC
isoforms with an N-terminal myc epitope tag. They were subsequently fixed and
immunostained with a polyclonal anti-myc antibody (Santa Cruz) followed by an
AlexaFluor-488 conjugatetd anti-rabbit secondary antibody. Topro-3 and
AlexaFluor 546 conjugated phalloidin were used to visualize the nucleus and
actin cytoskeleton respectively. Laser scanning confocal microscopy with a 100x
objective was used to obtain all images. Panels from left to right demonstrate the
localization of the ASC isoforms (green), nuclei (blue), the actin cytoskeleton
(red), and a merged composite image.
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Figure 3. ASC isoforms exhibit different co-localization patterns with o ther
key inflammasome proteins and have a diminished capacity to elicit
inflammasome activation.
HEK 293 cells were transiently co-transfected using Polyfect (Qiagen) with
individual ASC isoforms and either GFP-tagged NALP3 R260W (A), or GFP-tagged
pro-caspase-1 C/A mutant (B). They were subsequently fixed and
immunostained with a polyclonal anti-myc antibody (Santa Cruz) and AlexaFluor
546-conjugated anti-rabbity secondary antibody. Topro-3 was used to visualize
the nucleus. All images were acquired using laser scanning confocal microscopy
with a 100x oil-immersion objective. Panels from left to right show ASC isoforms
(red), GFP-NLRP3(R260W) (A) or GFP-pro-caspase-1(C/A) (B) (green), nuclei
(blue), and a merged image.
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(C). Inflammasomes consisting of a constitutively active NALP3R260W, pro-IL1beta, pro-caspase-1, and one of the ASC isoforms were transiently
reconstituted in HEK 293 cells as indicated using Superfect (Invitrogen). 48
hours post-transfection, the supernatants were collected, cleared by
centrifugation, and analyzed for secreted IL-1beta by ELISA. Results represent
an average of three independent experiments +/- SD and are presented as
pg/mL of secreted IL-1beta.
(D). In vitro binding between ASC a, ASC b, and caspase-1 CARD. Myc-tagged
ASC a and ASC b were in vitro translated, and subjected to GST pull-down
assays using GST-Caspase-1 CARD, and a GST control. Protein complexes
were separated by SDS-PAGE, transferred to a PVDF membrane, and visualized
by immunoblotting with anti-myc antibody.

154

Figure 4. Co-localization of ASC b and ASC c with the full length ASC a.
HEK 293 cells were transiently co-transfected using Polyfect (Qiagen) with
individual ASC b or ASC c and an HA-tagged full-length ASC a. They were
subsequently fixed and immunostained with a monoclonal anti-myc antibody
(Millipore) and a polyclonal anti-HA antibody (Abcam) followed by AlexaFluor 488 anti-mouse and AlexaFluor 546-conjugated anti-rabbity secondary
antibodies. Topro-3 was used to visualize the nucleus. All images were acquired
using laser scanning confocal microscopy with a 100x oil-immersion objective.
Panels from left to right show ASC b or ASC c (green), ASC a (red), nuclei (blue),
and a merged image.
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General Discussion

Physicians and scientists have long observed a connection between the
process of inflammation and tumor development and progression. As early as
the 1800’s, Virchow proposed a direct link between inflammation and cancer
based upon the enhanced proliferation observed in both disease states.
Although increased cellular proliferation is not sufficient to induce cell
transformation, Virchow’s observation was not without merit. As our
understanding of tumor cell biology and how it is impacted by inflammatory
cytokines has evolved over the years, we have realized that these two processes
are intimately intertwined. IL-1beta is an extremely potent pro-inflammatory
cytokine, which has also been shown to participate at multiple levels of tumor
progression including angiogenesis, recruitment of TAMs, and the upregulation of
proliferation and survival genes (Apte, 2002,Apte RN, 2006a). Furthermore, the
ability of IL-1beta to increase its own transcription via binding to IL-1R1 and
subsequent NF-kB activation enhances its ability to sustain its production in the
tumor microenvironment.
Recent studies in patients with autoinflammatory periodic fever syndromes
have revealed how bypassing a key regulatory step in the production of mature
IL-1beta can dramatically increase its production. In 2007, Gattorno et al.,
published an intriguing study examining IL-1beta secretion in monocytes from
patients with disease-causing mutations in the NLRP3 gene. They determined
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that monocytes from these patients released greater amounts of IL-1beta in
response to inflammatory activation, which was not enhanced upon addition of
ATP. These results suggest that there is already an elevated level of caspase-1
activation present in the monocytes from these patients. Interestingly, treatment
of these patients with recombinant IL-1Ra (anakinra) in vivo, resulted in a
decrease in the release of IL-1beta from their monocytes in vitro (Gattorno M,
2007). An independent research group also obtained similar results with this
treatment (Goldbach-Mansky R, 2006). These results demonstrate that blocking
the activity of IL-1beta results in a decrease in further IL-1beta release and that is
IL-1beta itself interacting with the IL-1R in an autocrine manner, which drives the
prolonged inflammatory episodes. Therefore, dysregulation of the inflammasome
can result in a self-sustaining increase in IL-1beta release in the tumor
microenvironment, which can promote tumor progression and metastasis.
Through our cumulative studies we have showed that inflammasome
activation and subsequent IL-1beta maturation is regulated through modulation of
the adaptor protein ASC. First, we demonstrated that endogenous ASC must be
redistributed from the nucleus to the cytoplasm in order for inflammasome
assembly to take place. We provide the first evidence that the perinuclear
aggregates formed by overexpression of ASC, do in fact occur on an
endogenous level in response to inflammatory activation. Furthermore, these
perinuclear aggregates incorporate other key inflammasome proteins including
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both caspase-1 and NLRP3 and therefore, are likely to represent assembled
inflammasomes.
Our discovery that endogenous ASC is localized to the nucleus in resting
monocytic cells raises the question of what function it may perform there. As we
demonstrated in study 1, the NLR receptors as well as IL-1beta itself are
confined to the cytoplasm. Therefore, any function carried out by ASC in the
nucleus must be independent of inflammasome assembly. One possibility is that
nuclear ASC modulates NF-kB activation. As mentioned above, several
independent studies have linked ASC to NF-kB activity, although there is
disagreement regarding whether it is an activator or an inhibitor of this important
transcription factor (Masumoto, 2003,Stehlik, 2002,Taxman, 2006). Indeed,
differences in NF-kB activity observed when expressing low levels of ASC versus
high levels of ASC (Sarkar, 2006) may be due in part to localization of ASC as
ASC is frequently nuclear when overexpressed at low levels and forms a
cytoplasmic aggregate at higher levels (data not shown). This possible function
of ASC in the nucleus is supported by our data showing co-localization between
nuclear ASC and caspase-1, which also functions as a modulator of NF-kB
activity. Therefore, further studies will need to be undertaken in order to address
how the subcellular distribution of ASC impacts NF-kB activity.
The finding that the availability of cytoplasmic ASC serves as a key
regulatory mechanism in inflammasome assembly is particularly intriguing in the
context of cancer. It has been well documented that tumor cells of all types
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frequently secrete IL-1beta, and that inhibition of that secretion severely impairs
their ability to grow and metastasize (Apte RN, 2006b,Voronov, 2003). However,
as mentioned above, ASC is silenced by methylation in a large number of diverse
tumors, presumably because of its role in pro-apoptotic pathways. Thus, in
tumor cells, it appears that ASC performs dual functions, which are at odds with
each other.
There are several possible mechanisms by which tumor cells may resolve
the antagonistic roles of ASC. First, they may simply bypass the requirement for
ASC by generating active caspase-1 through another mechanism. Genetic
destabilization may result in a large increase in the production of pro-caspase-1.
As activation of caspase-1 is actually achieved through an induced proximity
mechanism, a large increase in protein production could be sufficient to bring
several molecules into close contact. Indeed, this is a phenomenon that we have
observed in overexpression studies (data not shown). Alternatively, tumor cells
could also release pro-IL-1beta, which would be subsequently processed by nonspecific extracellular proteases. This would bypass all regulatory mechanisms
associated with inflammasome activation.
Further insight into how tumor cells resolve the antagonistic roles of ASC
can be provided by recent studies, which examined when the methylationinduced silencing of ASC occurs. Studies in patients with colon and lung cancers
found that silencing of ASC is a late-stage event (Machida, 2006,Riojas MA,
2007). Therefore, it is possible that tumor cells maintain ASC expression in early
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stages in order maintain their ability to release IL-1beta and subsequently recruit
inflammatory cells such as macrophages to the tumor site. As the tumor
progresses and the inflammatory infiltrate becomes established, the TAMs can
then assume the responsibility of maintaining elevated levels of IL-1beta in the
tumor microenvironment. This hypothesis is supported by immunohistochemistry
data showing that in breast cancers, which have completely silenced ASC
expression, it is still expressed in the surrounding inflammatory cells (Parsons
MJ, 2009).
Our studies also revealed the existence of novel isoforms of ASC. We
focused on how the structural modifications of ASC influenced the ability of each
isoform to participate in inflammasome assembly. Of the three isoforms we
identified, only one, ASCb, retained was able to mediate inflammasome
assembly, albeit with less efficiency than full-length ASCa. Intriguingly, in our
search of the EST database, which led to the identification of these isoforms, we
found that they were preferentially expressed in tumor tissue samples over the
normal tissue couterparts. This suggests that expression of the ASC isoforms
confers a selective advantage onto tumor cells. One possible explanation is that
these isoforms provide an alternative mechanism by which tumor cells may
escape the pro-apoptotic effects of ASC.
Our study did provide some evidence that these isoforms may be
defective in their ability to participate in cell death. First, most studies of ASCinduced cell death have found that ASC localizes into a perinuclear aggregate
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prior to the cell’s demise. This has been demonstrated for both apoptotic as well
as pyroptotic forms of cell death (Masumoto, 1999,McConnell, 2000,T
Fernandes-Alnemri, 2007). None of the isoforms we identified were capable of
forming the characteristic ‘speck’ when overexpressed on their own. Although
ASCb did aggregate in the presence of constitutively active NLRP3 and fulllength ASCa, the aggregates were larger and more irregularly shaped compared
to those formed by ASCa. Furthermore, as previous studies examining the
mechanism by which ASC induces apoptosis have found that the PYD is
essential, the structural modifications observed in ASCc and ASCd are likely to
render them incapable of participating in those pathways (Masumoto,
2003,Ohtsuka, 2004). Although ASCb possesses an intact PYD, its lack of a
linker domain could make it less effective in mediating apoptosis, as was the
case for its ability to mediate inflammasome assembly. Thus, further studies
evaluating the capacity of each of these isoforms to function in cell death
pathways are warranted.
The mounting evidence in favor of a role for IL-1beta in a number of
disease processes including autoinflammatory disorders, CNS injury, in addition
to cancer makes it an attractive therapeutic target. Indeed, anakinra is being
evaluated for its ability to provide relief to patients suffering from FMF that is no
longer responding to colchicine, gout, pseudo-gout, and the cryopyrinopathies
with encouraging results (McGonagle D, 2007,McGonagle D, 2008,Roldan R,
2008,Ross JB, 2008,So A, 2007,Zhou, 1999). Furthermore, studies of in vivo
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tumor models have revealed that diminished IL-1beta secretion results in slower
tumor growth and diminished invasiveness. Interestingly, the results are
consistent regardless of whether it is the tumor cells or the host, which lack the
capacity to release IL-1beta. Therefore, adjuvant treatment of cancer,
particularly those that are associated with chronic inflammatory conditions such
as gastric cancer, with anakinra or an IL-1beta neutralizing antibody may warrant
future investigation.
In addition, the work presented here offers the potential for a new
therapeutic target: inhibiting the nuclear export of ASC. As previously
mentioned, tumor cells frequently target ASC for methylation-induced silencing.
Therefore, complete neutralization of this protein would likely have protumorogenic effects. However, restricting ASC to the nucleus would prevent
inflammasome assembly and subsequent IL-1beta processing without eliminating
the protein. Furthermore, if the nuclear function of ASC involves the inhibition of
NF-kB activity, then this method would an additional impact by preventing the
transcription of multiple pro-survival and proliferative genes.
In summary, the work presented here that modulation of the
inflammasome adaptor protein ASC through regulation of its subcellular
localization and through alternative splicing can have significant impact on
inflammasome assembly. We also identified Mycoplasma sp. as a novel
activator of the inflammasome, which could have implications in the treatment of
diseases caused by this organism as well as the inflammatory disorders that
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have been linked to it. Further exploration of the clinical relevance of ASC
modulation as well as the potential for therapeutic targeting of these mechanisms
is warranted.
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